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Abstract 
Recent studies have established oxysterol-binding protein (OSBP) and 
members of the OSBP-related protein (ORP) family as global cellular sterol 
sensors that participate in non-vesicular anterograde transport of monomeric 
sterols from the endoplasmic reticulum to other organelles such as the Golgi 
and the plasma membrane. By exchanging sterols for phosphoinositides, 
these multi-domain proteins change the bilayer composition at membrane 
contact sites and thus, regulate various signaling pathways. 
Despite the wealth of knowledge garnered from the study of 
fluorescent/radiolabeled ligand-protein interactions and inter-vesicular lipid 
transfer assays in vitro, the precise nature of the association of ORPs with 
organellar membranes and the factors modulating such interactions have 
remained largely enigmatic. The goal of my project was to characterize the 
behaviour of human OSBP using a label-free analytical technique called dual 
polarization interferometry (DPI). This technique enables surface-
immobilization of phospholipid vesicles to observe and analyze the behaviour 
of proteins towards adsorbed bilayers. 
From my investigation, I found that OSBP prefers binding to 
membranes containing anionic phospholipids, such as phosphatidylinositol-4-
phosphate (PI(4)P), over membranes made up of neutral phosphatidylcholine 
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(PC). In the presence of PI(4)P, the wild-type protein clearly demonstrated a 
rapid bilayer association, followed by PI(4)P extraction and a slower 
dissociation, in a dosage-dependent fashion. The OSBP-related domain (ORD) 
mutant, OSBP-HH/AA, due to its impaired ability to extract PI(4)P, failed to 
dissociate from the membrane while the pleckstrin homology domain (PHD) 
mutant, OSBP-RR/EE, could not associate with membranes at all. The 
presence of sterols did not alter OSBP’s affinity for PC membranes despite a 
two-fold increase in protein adsorption per unit area in the presence of 
cholesterol in the membrane, compared to 25-hydroxycholesterol. 
Both cholesterol and 25-hydroxycholesterol competed with 22-NBD-
cholesterol for the binding site in the ORD of OSBP, with resulting EC50 
values of 15.6 ± 0.7 nM for the former and 5.0 ± 0.5 nM for the latter. OSBP 
also transferred ORD-bound fluorescent cholesterol to acceptor vesicles, but 
the rate remained unaltered upon incorporation of PI(4)P in those 
membranes.  
 These results provide useful insight into the preferential association of 
OSBP with membranes containing specific recognizable ligands, such as 
sterols and PI(4)P, and help build a molecular level description of the 
mechanism of this protein.  
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Chapter 1 
INTRODUCTION 
Oxysterol-binding protein (OSBP) is a sterol transfer protein known to 
facilitate anterograde transport of cholesterol and its oxygenated derivatives 
from the endoplasmic reticulum to other organellar membranes in eukaryotic 
cells. This chapter provides an overview of the origin and significance of 
oxysterols along with a description of various non-vesicular modes of 
intracellular lipid trafficking. Also highlighted are the biological roles of the 
members of the OSBP-related protein (ORP) family in diverse signaling 
pathways and the molecular interactions of their structural domains with a 
wide range of lipid ligands. The current progress in the field of ORP research 
and the popular models explaining the mechanism of ligand exchange by 
mammalian OSBP and yeast Osh4 are discussed here. A breakdown of the 
primary goal of this project is provided with detailed background information 
on the techniques utilized to achieve the research objectives. 
 
Chapter 1 | INTRODUCTION 
 
 
Page | 2  
1.1. Oxysterols 
Oxysterols are oxygenated derivatives of cholesterol that have been 
extensively researched for their involvement in sterol homeostasis. In recent 
years, these biologically active compounds have gained much interest due to 
their newfound roles as regulators of signaling pathways, as ligands for novel 
receptors, as components of the cell’s immune response and as crucial 
biomarkers for atherosclerosis and neurodegenerative diseases. This section 
will, however, focus on the origin and role of these chemical species in the 
regulation of cholesterol metabolism. 
 
1.1.1. Origin of oxysterols 
Oxysterols can be classified into two major varieties based on the 
number of structural modifications. While primary oxysterols have single 
substitutions either in the side chain or the aromatic rings of cholesterol, the 
secondary oxysterols feature multiple functionalities including hydroxyl, 
epoxy, keto, or hydroperoxy groups (Olkkonen and Lehto, 2004). Oxysterols 
are known to be synthesized both enzymatically as well as non-enzymatically 
and can either be produced endogenously or acquired from the diet. Figure 1 
provides a summary of the chemical structures of various oxysterols 
originating either directly or indirectly from cholesterol. In the chemical 
structure of cholesterol, the presence of a double bond between C5 and C6 
positions makes the seventh carbon of the B ring prone to any free-radical 
attack, thereby causing non-enzymatic transformation of the parent 
molecule. 7-α/β-hydroperoxycholesterol (7OOHC) is produced in this fashion 
(Brown and Jessup, 2009). The biological function of this species has 
remained largely elusive despite its presence in low-density lipoproteins 
(LDL) (Brown et al., 1997; Terao, 2014).  
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Figure 1: Chemical structures of some oxysterols. Oxysterols originate from 
cholesterol by the action of various cytochrome P450 enzymes (CYPs) or from 
reactive oxygen species (ROS). Some members, such as 24(S),25-epoxycholesterol, 
originate from the cholesterol precursor by the action of CYP46A1. 
 
While the non-enzymatic oxidation of cholesterol via free radicals 
remained the centre of research during the 80s and the 90s, the post-2000 era 
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witnessed a shift of interest to enzymatically-derived oxysterols. Most of 
these enzymes belong to the cytochrome P450 (CYP) superfamily located in 
the ER. For example, 22(R)-hydroxycholesterol (22HC) is produced by 
CYP11A1 as an intermediate during the biosynthesis of steroid hormones 
(Mast et al., 2011). Likewise, the formation of 27-hydroxycholesterol (27HC) 
is catalyzed by CYP27A1 in several cell types, such as macrophages, during 
the “acid pathway” of bile acid biogenesis (Cali and Russell, 1991; Björkhem 
et al., 2002). Some oxysterols are generated to serve unique purposes in 
specialized cells, such as 24(S)-hydroxycholesterol (24HC) by CYP46A1 in 
neurons (Bretillon et al., 2007) and 7-α,25-dihydroxycholesterol (7α,25DHC) 
by CH25H (cholesterol 25-hydroxylase – a reductase/hydroxylase located in 
the mitochondrial matrix) and CYP7B1 in B-lymphocytes and dendritic cells 
(Cyster et al., 2014). Some oxysterols are also generated by the action of 
multiple enzymes. A common example is 24(S),25-epoxycholesterol 
(24,25EC), which is not derived directly from cholesterol. Instead, it is 
produced by CYP46A1 from desmosterol, a penultimate member of the 
classical cholesterol biosynthetic pathway, via a shunt of the pathway 
through a dioxidosqualene intermediate (Ali et al., 2013; Wang et al., 2014). 
Several oxysterol species can arise via both enzymatic and non-
enzymatic reactions. A key example is 7-ketocholesterol (7KC). It is a 
common breakdown product of 7OOHC but is also known to be converted 
from 7-dehydrocholesterol, an alternate product of lanosterol in the 
cholesterol biogenesis (the primary product being desmosterol), by CYP7A1 
(Shinkyo et al., 2011). Other non-enzymatic degradation products of 7OOHC 
include 7-α-hydroxycholesterol (7αHC) and 7-β-hydroxycholesterol (7βHC). 
Nevertheless, they are also generated by CYP7A1 and the cortisone reductase 
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), respectively (Russell, 
2003; Mitić et al., 2013). 7αHC is a major intermediate in the “neutral 
pathway” of bile acid biogenesis. The most commonly studied species of 
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oxysterol, 25-hydroxycholesterol (25HC), is an inhibitor of cholesterol 
biosynthesis and LDL receptor expression in cell models. A remarkable 
uniqueness of 25HC stems from its diverse modes of origin. It is the only 
oxysterol that is generated by three independent routes: autoxidation of aged 
or crystalline cholesterol (Diczfalusy, 2013), as a major product of CH25H 
activity (Lund et al., 1998) and also in minor quantity by CYP27A1, CYP46A1 
or CYP3A4 (Luu et al., 2016). However, due to its low abundance in human 
tissues compared to other non-enzymatically produced oxysterols, 
autoxidation of 25HC in vitro and in vivo remains questionable at present.  
 
1.1.2. Oxysterol metabolism 
Oxysterols primarily undergo esterification of the β-hydroxyl group at 
the C3 position by two classes of acetyltransferases which are also known to 
act on cholesterol: lecithin-cholesterol acetyltransferase (LCAT) (Glomset, 
1962) and acetyl-CoA-cholesterol acetyltransferase (ACAT) (Chang et al., 
1993). In addition to the formation of various oxysterol esters, hydroxylation 
of 25HC by CYP7B1 gives rise to 7α,25DHC, as mentioned earlier (Martin et 
al., 2001). Sulfotransferases, such as hydroxysteroid sulfotransferase 2B1b 
and 2A1 (SULT2B1b and SULT2A1), also modify oxysterols by sulfonating 
either the 3β-hydroxyl or both 3β- and 25-hydroxyl groups of 25HC (Li et al., 
2007; Ren et al., 2014). Sulfonation has been reported to alter the native 
function of various oxysterols and an increased level of circulating oxysterol 
sulfates leads to several pathological conditions (Sánchez-Guijo et al., 2015). 
Like sulfonation, oxysterols can also undergo glucuronide conjugation. This is 
evident from the high levels of sulfate/glucuronide double conjugates of 24HC 
and 27HC in the serum and urine of children with severe cholestatic liver 
disease (Meng et al., 1997). Enzymes responsible for the glucuronidation of 
oxysterols belong to the uridine diphosphate (UDP)-glucuronosyltransferase 
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(UGT) family that account for the majority of phase II metabolism in humans 
(Björkhem et al., 2001; Verreault et al., 2006).  
 
1.1.3. Impact of oxysterols on cholesterol homeostasis 
Kandutsch and co-workers formulated the “Oxysterol Hypothesis of 
Cholesterol Homeostasis” in 1978 when they postulated that cholesterol 
exhibits a negative regulatory effect on its own biosynthesis, not by itself, but 
with the help of its oxygenated forms, called oxysterols. Using mouse 
lymphocytes (Chen et al., 1975), human fibroblasts (Breslow et al., 1975) and 
Chinese hamster lung cells (Chen et al., 1979), they were able to show that an 
impure sample of cholesterol containing trace amounts of oxysterols, was able 
to inhibit cholesterol synthesis whereas pure cholesterol did not (Kandutsch 
et al., 1978). Although their work was initially subjected to scrutiny and 
criticism, almost four decades of research has reshaped the historical 
hypothesis and established beyond doubt that oxysterols play a major role in 
the regulation of cholesterol homeostasis at both transcriptional and post-
translational levels. 
 
1.1.3.1. Transcriptional regulation: 
Two major transcriptional regulators of cholesterol metabolism are the 
sterol regulatory element binding proteins (SREBPs) and the liver X 
receptors (LXRs). An example of a gene transcribed by the former is 3-
hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase and an 
example of a gene regulated by the latter is LDL receptor (Gill et al., 2008). 
Specific isoforms of SREBPs control the expression of genes involved in 
both cholesterol biosynthesis and uptake. Mechanistically, SREBPs occur in 
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the ER as membrane-bound precursors and they are associated with a 
cholesterol-sensing SREBP-cleavage-activating protein (SCAP) which 
undergoes conformational changes upon ligand binding. In response to low 
cellular cholesterol levels, SCAP facilitates localization of the SCAP-SREBP 
complex to the Golgi where SREBP is activated by sequential proteolytic 
cleavage and released to the nucleus as a soluble transcription factor to 
target specific genes involved in cholesterol synthesis (Goldstein et al., 2006). 
When there are sufficient levels of cholesterol in the cell, cholesterol binds to 
SCAP which prevents the departure of SCAP-SREBP complex from the ER by 
a retention protein, named Insig. This, in turn, prevents SREBP activation 
(Brown et al., 2002). 
Due to the presence of a substantial amount of evidence in support of 
the fact that only cholesterol, and not oxysterol, can bind to SCAP (Adams et 
al., 2004), it is not surprising to question the validity of the Oxysterol 
Hypothesis of Cholesterol Homeostasis. However, the discovery that Insig 
acts as an oxysterol sensing protein at the ER has certainly turned the tide in 
favor of the hypothesis (Radhakrishnan et al., 2007). Numerous studies have 
supported the reciprocity of the sterol-binding properties of SCAP and Insig. 
While SCAP can bind to the tetracyclic steroid framework and the 3β-
hydroxyl group of cholesterol, the presence of a polar group on the side-chain 
disrupts this association. In contrast, binding to Insig is made possible only 
by a polar group on the side-chain. Therefore, a revised model supports that 
both cholesterol and oxysterol regulate cholesterol homeostasis via two very 
similar, yet separate, modes of inhibiting SREBP activation: binding of 
cholesterol to SCAP and binding of oxysterol to Insig. 
Unlike SREBPs, regulation of cholesterol homeostasis via LXRs is a 
consequence of direct binding of oxysterols with this superfamily of ligand-
activated nuclear hormone receptors. LXRs are incapable of binding to 
cholesterol and cholesterol esters but can effectively bind oxysterols because 
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of their structural preference to accommodate side-chain hydroxyl, keto or 
expoxide groups (Janowski et al., 1999). The levels of the oxidized derivatives 
closely reflect the cellular cholesterol status. Upon ligand binding, LXRs 
dimerize with retinoid X receptors and recruit co-activators that result in 
transcriptional activation of a network of genes involved in reverse 
cholesterol transport, cholesterol catabolism and lipogenesis (Willy and 
Mangelsdorf, 1997; Ignatova et al., 2013). In cells and tissues experiencing 
high cholesterol flux, LXRs upregulate the expression of ATP-binding 
cassettes (ABC). ABCA1 and ABCG1 are two such proteins which play an 
important role in cholesterol removal from macrophages (Vaughan and 
Oram, 2006). Various in vitro and in vivo experiments have suggested that 
naturally occurring oxysterols with oxygenated side-chains, such as 24-, 25- 
and 27HCs, serve as natural ligands for LXRs (Brown and Jessup, 2009). 
Overexpression and gene knockout studies have provided compelling 
evidence in favor of the bona fide involvement of endogenous 24,25EC in 
transcriptional control of ABCA1 in an LXR-dependent manner (Wong et al., 
2008). 
 
1.1.3.2. Post-translational regulation:  
Oxysterols are involved in fine-tuning the activity of various enzymes. 
HMG-CoA reductase, which catalyzes the conversion of HMG-CoA to 
mevalonate – a classic rate-limiting step of cholesterol biogenesis, is known to 
be degraded by side-chain-derivatized oxysterols via Insig signaling (DeBose-
Boyd, 2008). Another example is inhibition of 24-dehydrocholesterol 
reductase by 24,25EC (Zerenturk et al., 2012). Certain ring-derivatized 
oxysterols (such as 7αHC) are known to promote degradation of squalene 
monooxygenase, another rate-limiting enzyme of cholesterol synthesis 
pathway (Gill et al., 2011).  
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1.2. Intracellular Lipid Trafficking 
Biogenesis and intracellular distribution of lipids are highly 
compartmentalized phenomena. Although different lipids are known to 
originate from various organelles, the primary site of lipogenesis in 
eukaryotic cells is the endoplasmic reticulum (ER). Unlike proteins, lipids 
lack specific targeting motifs to mediate their cellular distribution, yet over a 
thousand chemically distinct species of lipids in eukaryotic cells find their 
niche in specific compartments giving rise to characteristic compositions of 
each organelle membrane. For example, plasma membrane (PM) in cultured 
fibroblasts is known to harbour ~60 – 80 % of total cellular cholesterol on a 
molar basis, which represents 30 – 40 % of the PM surface (Lange et al., 
1989; Lange, 1991; Liscum and Munn, 1999). In spite of being synthesized at 
the ER, cholesterol occupies only 3 – 6 % of ER membrane, which is a mere 
0.5 – 1 % of the total cholesterol content of a cell (Lange et al., 1999; Liscum 
and Munn, 1999; Maxfield and Wüstner, 2002).  The interior of the cell can 
therefore be envisioned as a complex network of highways by means of which 
diversified cargoes of lipid are transported in every direction.  
 
1.2.1. Vesicle-mediated transport 
The intracellular transport of lipids occurs via different mechanisms. 
Among these, the most prominent means is the vesicle-mediated transport. It 
is an active phenomenon wherein a portion of a donor membrane forms 
tubular structures that encapsulate a payload of specific proteins and lipids, 
bud-off and subsequently fuse with an acceptor membrane (Gillon et al., 
2012). Since lipids form the basic structural backbone of transport vesicles, it 
is apparent that large amounts of lipids are transferred between membranes 
by endocytic and exocytic pathways. Specialized signaling motifs in the 
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cytoplasmic domains of transmembrane proteins help them interact with 
other peptides which facilitates their inclusion in budding vesicles. 
More sophisticated cargo sorting can occur, as is the case for LDL 
receptors internalized by coated pits (Goldstein et al., 1981). Upon delivery to 
sorting endosomes, LDL is dissociated from its receptor due to the acidic pH 
of the endosomal compartment (Maxfield and McGraw, 2004). The nascent 
vesicles budding from the surface of endosomes have a high surface area to 
volume ratio compared to that of the organelle itself. This results in efficient 
sorting and removal of LDL receptors into the vesicles, while the soluble LDL 
is retained. 
Unlike proteins, the underlying mechanisms of lipid sorting into 
transport vesicles are not well understood. In the PM, cholesterol associates 
with sphingolipids to form lipid-ordered micro-domains. Experimental 
evidence suggests that spatial segregation of protein contents of synaptic 
vesicles into lipid raft domains is facilitated by sterols (Lv et al., 2008). Using 
a lipidomics approach, Simons and co-workers demonstrated that the trans-
Golgi network (TGN) of S. cerevisiae was capable of sorting membrane lipids, 
such as ergosterol, into secretory vesicles that exhibited higher membrane 
order (Klemm et al., 2009). However, the vesicle-mediated transport may not 
be the major mode of sterol trafficking inside a cell. For instance, only 20 % 
reduction in the transport of newly synthesized cholesterol from the ER has 
been observed in baby hamster kidney (BHK) fibroblasts treated with 
vesicular transport inhibitor Brefeldin A (Damke et al., 1991; Heino et al., 
2000). Likewise, ergosterol transport remains unaffected in yeast cells 
expressing a defective version of Sec18, an essential protein for anterograde 
vesicle transport from the ER (Baumann et al., 2005). 
Maxfield’s laboratory has studied the intracellular sterol transport 
using a naturally occurring fluorescent sterol named dehydroergosterol 
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(DHE). By measuring the fluorescence recovery after photobleaching (FRAP), 
his group was able to estimate the rate of transport of DHE into endocytic 
recycling compartments (ERCs) in Chinese hamster ovary (CHO) cells. 
According to them, the magnitude of fluorescence recovery was reduced only 
slightly when ATP was depleted from the cells (Hao et al., 2002). In light of 
the fact that ATP provides energy that drives vesicular transport, these 
results suggest that a significant proportion of sterol cargo in the cell is 
delivered to its destination by non-vesicular means.   
 
1.2.2. Non-vesicular transport 
Non-vesicular movement of lipids involve a multitude of closely-related 
processes as outlined in Figure 2. These processes can be broadly classified 
into three modes: spontaneous, transbilayer and lipid transfer protein (LTP)-
mediated transport. 
 
Figure 2: Various modes of non-vesicular lipid transport. Monomeric lipids 
can be transported in a non-vesicular fashion inside the cell by three mechanisms: 
spontaneous, transbilayer (flip-flop or lateral diffusion), and LTP-mediated 
transport. LTP-mediated transport can be unidirectional (from donor membrane to 
acceptor membrane) or bidirectional (shuttle/exchange between two membranes). 
Flip-flops can be spontaneous or mediated by flippases and translocases (Lev, 2010). 
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1.2.2.1. Spontaneous transport:  
Spontaneous disruption of lipid-lipid interaction at the membrane 
surface, followed by desorption of lipid molecule in a cavity formed in the 
aqueous phase, allow for free diffusion of lipids in their monomeric forms 
through the cytosol, before being incorporated into a bilayer. Lipid 
movement/exchange can take place between two separate membrane bilayers 
or within the lateral plane of the same bilayer (Lev, 2010). Sometimes, two 
membranes collide and result in lipid exchange. A slightly modified form of 
collision-mediated transfer involves extension of the lipid from the donor 
membrane surface, which not only reduces the energy cost of the transfer to 
the acceptor membrane but also increases its probability. This is called 
activated collision. While aqueous diffusions mainly occur at low membrane 
concentrations, collision-based transfers take place at high membrane 
concentrations. Both processes are concentration-dependent. On one hand, 
aqueous diffusion follows first-order reaction kinetics in which the rate is 
defined by concentration of the donor membrane only (Lev, 2010).  On the 
other hand, collisions are second-order processes wherein the transfer rates 
are determined by the concentrations of both donor and acceptor membranes 
(Lev, 2010). 
Spontaneous diffusions are energetically unfavorable and extremely 
slow processes in the aqueous milieu of the cytosol due to the hydrophobic 
nature of most lipids. The rates of such transfers are proportional to the 
aqueous-phase solubility of the participating sterol (or phospholipid) species. 
For example, t1/2 of spontaneous transfer of 25HC, cholesterol and cholesterol 
oleate have been reported as 2 min, 2 h and 107 h, respectively (Lev, 2010). 
Therefore, for this process to be more efficient, the donor and recipient 
membranes should be in close proximity. Existence of small cytosolic gaps, 
measuring 10-30 nm, formed by close apposition of ER membranes with other 
organelles, such as Golgi, PM, peroxisomes, mitochondria, etc., has attracted 
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a lot of interest in recent years. Current studies have elucidated the 
significance of these membrane contact sites (MCSs) in lipid biosynthesis, 
Ca2+ signaling and transport of metabolites (Helle et al., 2013; Phillips and 
Voeltz, 2015). MCSs not only facilitate non-vesicular transport of lipids by 
spontaneous diffusion but they also provide an active platform for lipid 
transport proteins (LTPs) to function (Mesmin et al., 2013). 
 
1.2.2.2. Transbilayer transport:  
Lipids can be transported between the two leaflets of a membrane 
bilayer either spontaneously or by the help of flippases and translocases 
(Hankins et al., 2015). Although the flip-flop mechanism of transbilayer lipid 
exchange does not directly contribute to inter-organellar lipid flux, it is 
thought to signal vesicle fission and fusion by presenting specific lipids on the 
surface. In addition, by changing the composition of bilayer leaflets, flip-flop 
transition enables creation of lipid micro-domains (or lipid rafts) within the 
bilayer and influences membrane curvature depending on the intracellular 
need (Contreras et al., 2010). While most translocases utilize the energy of 
ATP hydrolysis to irreversibly transport phospholipids across the leaflets, 
some flippases, called scramblases, are energy-independent and engage in 
establishing a reversible and bidirectional equilibrium of phospholipids. 
 
1.2.2.3. Transport mediated by lipid transfer proteins (LTPs):  
LTPs are capable of recognizing donor surfaces, either selectively via 
specialized structural motifs or non-selectively by virtue of the dual 
functionality of their lipid-binding domains to sense lipid gradients. Based on 
the properties of their hydrophobic binding pockets, LTPs extract and 
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transfer selective lipid monomers by shielding them from the aqueous 
environment and delivering them to their destined locations. The earliest 
account of study in this area dates back to 1968, when a non-dialyzable, heat-
labile, and trypsin-sensitive cytosolic factor, capable of transferring 
phosphatidylcholine (PC) between microsomes and mitochondria in rat 
hepatocytes, was first isolated by Zilversmit and colleagues (Wirtz and 
Zilversmit, 1968). These factors were later identified as proteins and were 
accordingly named “phospholipid transfer proteins” (Wirtz and Zilversmit, 
1970). Since this discovery, many LTPs have been isolated and characterized 
in bacteria, eukaryotes and plants. 
Although extensive research has been done over the past 30 – 35 years, 
the precise modes of action of LTPs have remained somewhat enigmatic. 
Moreover, the fact that these carriers mediate lipid transport against the 
concentration gradient over localized membrane microenvironment paints a 
rather intriguing picture in which their lipid sensing/transfer activity serves 
a secondary function in the regulation of complex metabolic and signaling 
pathways. Today, these proteins are subdivided into various families based 
on their structural and functional similarity, including but not limited to 
phosphatidylinositol (PI) transfer protein (PITP), steroidogenic acute 
regulatory protein (StAR)-related lipid transfer (START) domain proteins, 
glycolipid transfer protein (GLTP), sterol carrier protein 2 (SCP2), ceramide 
transfer protein (CERT) and oxysterol-binding protein (OSBP)-related 
proteins (ORPs). 
For the sake of simplicity, the information provided below is limited to 
ORPs only. Readers interested in other LTPs can find extensive reviews 
elsewhere (Lev, 2010; Clark, 2012; McDermott and Mousley, 2016). 
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1.3. Oxysterol-Binding Protein (OSBP)-Related Proteins 
(ORPs) 
Oxysterol-binding protein (OSBP)-related proteins (ORPs), constitute a 
large eukaryotic gene family that includes both mammalian proteins as well 
as those encoded by the OSBP homologue (OSH) gene family in yeast 
(Olkkonen et al., 2006). They primarily act as intracellular transporters of 
sterols and other phospholipids between various membranes compartments, 
such as ER, Golgi and PM. Since their discovery by Taylor and Kandutsch in 
1980s as cytoplasmic factors capable of binding oxygenated derivatives of 
cholesterol and suppressing HMG-CoA reductase (Taylor et al., 1984; Taylor 
and Kandutsch, 1985),  a significant amount of information about the nature 
and mode of action of OPRs has been acquired by researchers. 
Interestingly, the hypothesis that OSBP was involved in 25HC-
mediated suppression of sterol-regulated genes (Brown and Goldstein, 1974; 
Kandutsch and Chen, 1974; Lagace et al., 1997), was discarded when 25HC-
induced inhibition of HMG-CoA reductase was found to be independent of 
OSBP (Nishimura et al., 2005). Some aspects of the precise role of ORPs in 
intracellular trafficking of lipids, especially phosphatidylinositol phosphates 
(PIPs), still remain unknown. 
Recent advances in the field of ORP research have revealed that these 
proteins localize at MCSs and possess the ability to simultaneously associate 
with the two closely-apposed membranes and facilitate lipid transport 
between them (Mesmin et al., 2013). Therefore, in order to understand the 
mechanism of action of these LTPs, it is crucial to have a clear 
comprehension of their structural characteristics. 
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1.3.1. Domain organization of ORPs 
The yeast, Saccharomyces cerevisiae, has seven Osh proteins while 12 ORPs 
have been identified in human with four additional splice variants (Lehto et 
al., 2001). The organization of domains in both human and yeast is shown in 
Figure 3A. The founding member the ORP family, namely OSBP, is 
characterized by a C-terminal sterol-binding/transfer domain (Ridgway et al., 
1992; Lehto et al., 2001), commonly known as OSBP-related domain (ORD) 
and an N-terminal pleckstrin homology domain (PHD) that recognizes and 
targets phosphoinositides with high specificity (Lemmon and Ferguson, 
2001), facilitating protein localization to PIP-enriched membranes of 
organelles such as the Golgi (Levine and Munro, 2002) and PM (Lehto et al., 
2005). The ORD is found in all members of this family and is marked by a 
highly-conserved signature motif EQVSHHPP near its N-terminus. Some 
proteins of the Osh family, in fact, possess only the ORD. The examples are 
Osh4, -5, -6 and -7. Based on the gene structure and amino acid homology, 
human ORPs are classified into six subfamilies (Lehto et al., 2001). The 
members are designated as long (L) and short (S) variants based on the 
presence of the N-terminal PHD in addition to the ORD. 
The yeast family is subdivided into four categories: Osh1/2, Osh3, Osh4/5, 
and Osh6/7. With the exception of ORP2 in human and Osh4 – 7 in yeast, the 
PHD is found is all ORPs. OSBP and a few other ORPs also feature a unique 
motif comprised of two phenylalanines in an acidic tract (FFAT) that binds to 
vesicle-associated membrane protein (VAMP)-associated protein A (VAP-A) 
located at the ER (Wyles and Ridgway, 2004; Kaiser et al., 2005).  At their N-
terminal end, a very few ORPs are known to possess ankyrin (ANK) repeats, 
which carry minimal information that determines their intracellular 
localization to late endosomes (Sedgwick and Smerdon, 1999; Johansson et 
al., 2003). Yeast Osh3 is the only ORP that contains an N-terminal Golgi 
dynamics (GOLD) domain which facilitates protein-protein interactions  
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human OSBP in complex with human vesicle-associated membrane protein (VAMP)-
associated protein A (VAP-A) major sperm protein (MSP) domain (violet). Phe-359 
and Phe-360 sidechains are shown as stick models in black (Furuita et al., 2010). 
Protein Data Bank (PDB) IDs of the displayed structures are: B) 1ZHX, C) 3SPW, 
D) 2D9X, and E) 2RR3. 
 
(Anantharaman and Aravind, 2002). Both ORP5 and ORP8 contain C-
terminal transmembrane regions that help in anchoring the protein to the 
ER membrane (Galmes et al., 2016). Within each sub-family, ORPs show a 
greater than 70 % sequence identity, which hints towards their conserved 
biological functionality in human and yeasts (Tong et al., 2016). 
 
1.3.2. The OSBP-related domain (ORD) 
The defining feature of all members of the ORP family is a conserved 
C-terminal domain ORD which binds both sterols and phospholipids (Im et 
al., 2005; de Saint-Jean et al., 2011). Crystal structure elucidation of Osh4, by 
Im et al. in 2005, was an important milestone in OSBP research (Im et al., 
2005). In their work, they demonstrated that Osh4 (a.k.a. Kes1) consisted of 
the ORD only and lacked other domains commonly found in human ORPs. 
This gave evidence in favor of the largely cytosolic nature of Osh proteins 
which enabled then to diffuse freely throughout the cytoplasm, unlike 
Osh1, -2 and -3, which are more-or-less localized to certain compartments 
owing to the presence of additional domains at their N-termini. 
Osh4 contains 434 amino acids and the structure of its ORD revealed 
an incomplete β-barrel, formed by seventeen β-sheets, that constitute a 
hydrophobic tunnel for ligand-binding. The N-terminal subdomain (residues 
30-117), containing two β-strands and three α-helices, forged the remaining 
portion of the tunnel. The entrance to this hydrophobic pocket was covered by 
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an amphipathic α-helix attached to a flexible loop that formed a “lid”-like 
structure at the far N-terminus of the protein (residues 1-29).  
 
 
 
Figure 4: Interactions of 25HC and PI(4)P with the ORD of Osh4. The 
molecular interactions of the 3-hydroxyl (A) and 25-hydroxyl (B) groups of 25HC and 
the 1-phosphate (C) and 4-phosphate (D) groups of PI(4)P with the conserved 
residues of Osh4-ORD are shown. The β-barrel forming the binding pocket is 
coloured orange and the N-terminal lid is represented in magenta. The yellow 
spheres (in A and B) represent water of crystallization. The colour code used for the 
elements in the chemical structures: C = green, O = red, P = black, and N = blue. 
The images are prepared in Visual Molecular Dynamics (ver. 1.9.3) from the PDB 
structures 1ZHX (Im et al., 2005) and 3SPW (de Saint-Jean et al., 2011). 
(A) (B) 
(D) (C) 
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Although the above-mentioned features are limited to yeast ORDs, a 
high level of sequence similarity and like biochemical properties suggest that 
this structural fold is well conserved over all eukaryotic species. ORDs are 
known to accommodate single molecules of several types of sterols and 
phospholipids. The most commonly investigated ligands are cholesterol, 
ergosterol, oxysterols, phosphatidylinositol-4-phosphate (PI(4)P), and 
phosphatidylserine (PS). Sterols have been reported to interact with the 
internal cavity of the ORD (Figure 3B) in an orientation that allows the 3-
hydroxyl group to be buried at the very bottom of the β-barrel. The functional 
group is stabilized by water-mediated interactions with Gln-96 (Figure 4A), 
which forms a part of a cluster of polar residues at the underside of the 
tunnel (Im et al., 2005). 
The remarkable absence of any direct hydrogen bonds between the 
alkyl side chain-substituted hydroxyl groups of oxysterols and the conserved 
amino acids of Osh4 makes it difficult to fully comprehend the higher affinity 
of ORPs for oxysterols when compared to that for cholesterol (Dawson et al., 
1989a; Ridgway et al., 1992; Wang et al., 2002, 2008). While the 20- and 25-
hydroxyl groups of respective oxysterols communicate with the residues at 
the inner surface of the lid indirectly via relatively ordered water molecules 
(Figure 4B), the 7-hydroxyl group of 7HC does not form any hydrogen bonds 
with either water or the protein (Im et al., 2005). The interaction of the alkyl 
side chain of sterols with the “lid” residues lead to a “closed” conformation of 
the protein that creates a completely sealed environment for the bound sterol 
during inter-membrane transport (Im et al., 2005). The recognition of the 3-
hydroxyl group of sterols by the polar residues at the bottom of the ORD is 
not conserved among the ORP variants, which is the underlying reason for 
their diverse ligand specificities (Tong et al., 2016). For example, while sterol-
binding is a common theme for Osh4 and Osh5, the smaller hydrophobic 
pocket of Osh3 doesn’t allow for the same (Tong et al., 2013). 
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In 2011, Antonny and co-workers discovered that PI(4)P competitively 
bound to the same internal binding site of Osh4 as do sterols. With the 
determination of the crystal structure of Osh4 in complex with PI(4)P, it was 
revealed that the two acyl chains of the ligand made weak non-specific 
interactions with the hydrophobic sterol-binding pocket, while the headgroup 
was recognized and stabilized by both direct and water-mediated contacts 
with a shallow cavity near the tunnel entrance  (Figures 3C, 4C and 4D). 
The 4-phosphate group engages in directing hydrogen bonding with His-143 
and His-144 of the OSBP signature sequence and Arg-344. The 1-phosphate 
group, that acts as a connecting link between the glycerol moiety and the 
inositol ring of PI(4)P, establishes hydrogen bonds with Lys-109 and Lys-336. 
The hydroxyl groups of the inositol ring were found to mediate water-based 
interactions with various residues of the “lid” and an α-β-loop near the tunnel 
entrance (de Saint-Jean et al., 2011). The study also revealed that due to 
steric hindrance between His-143 and the 5-phosphate group, 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) could not be accommodated 
by Osh4. In human OSBP, His residues at positions 524 and 525 correspond 
to His-143 and His-144 of yeast Osh4, respectively. Therefore, His → Ala 
mutation at those sites, in the ORD of OSBP-HH/AA, renders the protein 
non-functional in terms of its ability to extract PI(4)P from membranes (Goto 
et al., 2016). 
Complete absence of in vitro sterol extraction and transfer activity has 
been observed in some ORPs. Instead, they participate in PS homeostasis by 
transporting the ligand from the ER to the PM in exchange for PI(4)P in vivo 
(Maeda et al., 2013; von Filseck et al., 2015b). One such example is Osh6. The 
crystal structure of its ORD in complex with PS shows much similarity with 
its PI(4)P-bound form. The binding pocket of Osh6 is slightly deeper than 
that of Osh4 and is mainly made up of hydrophobic residues. PS is known to 
insert one of its long acyl chains inside the tunnel while the headgroup and 
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the other acyl chain are accommodated around the entrance. The hallmark of 
PS recognition is the formation of hydrogen bonds between the carboxylate 
group of the PS headgroup and the α-β-loop of the “lid”, as well as with Ser-
183 in the wall of the β-barrel. Other residues at the entrance engage in 
hydrophobic interactions with the acyl chain (von Filseck et al., 2015b). Like 
Osh6, mammalian ORP homologs, ORP5 and ORP10, show poorer binding to 
cholesterol but increased preference for PS as a second lipid for exchanging 
PI(4)P at membrane surfaces (Maeda et al., 2013).  
 
1.3.3. The pleckstrin homology domain (PHD) 
PHDs are found in a variety of proteins families, including, but not 
limited to, Ser/Thr protein kinases, GTPases, regulators of small G-proteins, 
cytoskeletal proteins, PI-specific phospholipase C (PI-PLC) in mammals, 
ORPs, ceramide kinase, etc. (Rebecchi and Scarlata, 1998). This domain is 
well-known to facilitate protein localization to the Golgi apparatus by 
targeting both phosphoinositides and the Arf family of small G-proteins, 
which are abundant in the membrane of that organelle (Lemmon, 2007). 
Many ORPs harbour this ~120 amino acid-long domain at their N-terminal 
end. 
Characterized by a C-terminal amphipathic helix, and a PIP-binding 
cavity formed by two anti-parallel β-sheets (Figure 3D), this domain exhibits 
a low sequence conservation among various proteins due to variation in the 
length of the three interstrand loops connecting the seven-stranded β-
sandwich (Saraste and Hyviinen, 1995). These variable loops lie at the 
surface of the lipid bilayer when PHD interacts with membrane-bound 
phosphoinositides. This was demonstrated by Lemmon and Ferguson using a 
hypothetical model of interaction of the PHD with a membrane-bound 
phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) (Figure 5
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from the X-ray crystal structure of the PH domain of Dual Adapter for 
Phosphotyrosine and 3-Phosphoinositides (DAPP1) bound to inositol-1,3,4,5-
tetrakisphosphate (Ferguson et al., 2000). The negatively charged 
headgroups of PIPs are stabilized by the positively charged face of the 
domain projected towards the membrane (Lemmon, 2007). PHDs from 
different proteins have varying affinities for each species of PIP, ranging from 
micomolar to nanomolar range (Lemmon and Ferguson, 2001). For example, 
the PHD of pleckstrin shows weaker binding (Kd ≈ 30 µM) to PI(4,5)P2 as 
compared to the PHD of phospholipase C-_1 (PLC-_1) (Kd = 1.7 µM) (Yagisawa 
et al., 1994; Lemmon et al., 1995). 
 
 
Figure 5: A hypothetical model of interaction of DAPP1-PHD with 
membrane-bound PI(3,4,5)P3. A ribbon representation of the X-ray crystal 
structure of DAPP1-PHD (PDB ID: 1FAO), bound to the inositol-3,4,5-triphosphate 
headgroup of PI(3,4,5)P3 embedded in a model for a dimyristoylphosphatidylcholine 
bilayer, is shown. The image has been reprinted with permission from (Lemmon and 
Ferguson, 2001).  
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In human OSBP, Arg-109 and Arg-110 are known to be crucial for the 
recognition of PIP-bearing membranes  (Levine and Munro, 1998, 2002; Ngo 
and Ridgway, 2009; Goto et al., 2016). Loss of basicity at these sites due to 
Arg → Glu mutation hampers the protein’s ability to associate with 
membrane via PI(4)P-PHD interaction. The OSBP-RR/EE mutant, however, 
retains its ability to extract PI(4)P from membranes, due to an intact and 
functional ORD. (Goto et al., 2016).  
By interacting with various PIP species distributed throughout the 
endomembrane system, PHDs help in docking many LTPs to their target 
membranes, for example, ORPs, four-phosphate-adaptor protein 2 (FAPP2) 
and ceramide transfer protein (CERT) (Hanada et al., 2003; Im et al., 2005; 
Yamaji et al., 2008). While this domain targets Osh1, OSBP and ORP9L to 
Golgi, it guides ORP1L to late endosomes and ORP3, -6 and -7 to the PM 
(Tong et al., 2016). The overall membrane targeting of ORPs originate from a 
synergistic combination of PHD and other motifs such as ANK and FFAT. 
Furthermore, the simultaneous detection of both PI(4)P and Arf1-GTP at the 
Golgi by the PHD facilitate precise localization of OSBP to ER-Golgi MCSs 
and help in initiating PI(4)P-sterol exchange between the two organelles 
(Mesmin et al., 2013). 
 
1.3.4. The FFAT motif 
Many ORPs feature a consensus amino acid sequence of Glu-Phe-Phe-
Asp-Ala-X-Glu that enable these cytosolic proteins to localize at the ER. This 
conserved motif binds to the ER resident VAP-A, which is anchored to the 
membrane by its transmembrane domain. This protein has three main 
domains: an amino-terminal major sperm protein (MSP) homology domain, a 
central coiled-coil domain and a carboxy-terminal transmembrane helix (Lev 
et al., 2008). The FFAT motif of ORPs interact with the MSP domain that 
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folds to form an immunoglobulin like β-sandwich structure as shown in 
Figure 3E. The interaction happens by electrostatic interactions of the acidic 
residues, flanking the phenylalanines of FFAT, with the basic residues on the 
surface of the MSP domain (Kaiser et al., 2005). The phenylalanines also 
engage in favorable interactions with the conserved hydrophobic patch on 
VAP-A surface (Figure 6). Furuita et al., in 2010, identified an acidic patch, 
made of Asp-352, Glu-353, Asp-354, Asp-355, and Glu-356, upstream of the 
FFAT motif. In their study, they found that this patch enhances the binding 
affinity of FFAT by facilitating the formation of an intermediate complex 
with VAP-AMSP through ionic interactions (Furuita et al., 2010). 
 
Figure 6: Interaction of FFAP motif with VAP-A. The solution structure of two 
FFAT motif (green ribbon model) of human OSBP in complex with the MSP domain 
of human VAP-A (surface model). The Phe-359 and Phe-360 (yellow), and the 
flanking acidic residues (red) of OSBPFFAT, are displayed as stick models. The 
residues on the surface of VAP-AMSP are differentiated as: acidic (red), basic (blue), 
polar (white) and hydrophobic (yellow). The image is prepared in Visual Molecular 
Dynamics (ver. 1.9.3) from the PDB structure 2RR3, solved by NMR studies (Furuita 
et al., 2010). 
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1.3.5. Biological functions of various OPRs 
A number of studies have confirmed that the functions of ORPs are not 
limited to cellular sterol metabolism. OSBP, the founding member of this 
family, is known to recruit CERT to the Golgi, in the presence of 25HC. 
Resulting increase in the flux of ceramide to trans-Golgi facilitates 
sphingomyelin synthesis and release of diacylglycerol (DAG) (Perry and 
Ridgway, 2006). The PI(4)P-dependent recruitment of OSBP and CRET to 
Golgi by the PI/PC transfer protein Nir2 is responsible for regulating Golgi 
DAG levels and PI4P synthesis by PI4-kinases (Peretti et al., 2008). DAG and 
PI(4)P are both involved in controlling vesicle biogenesis from Golgi. 
Among the other members of the mammalian ORP family, the sterol 
sensor ORP1L acts as a scaffold in regulating the motility of late endosomes 
(LE) in cells (Rocha et al., 2009). Under low cholesterol condition, ORP1L 
facilitates the formation of ER-LE MCSs by interacting with the ER-resident 
VAP. This, in turn, causes movement of LEs to the plus end of microtubules 
due to removal of associated dynein/dynactin motor proteins from LEs. The 
process is prevented under high cholesterol conditions. 
ORP9, a member of the subfamily V, modulates phosphorylation of 
Akt/protein kinase B at its phosphoinositide-dependent kinase-2 (PDK-2) 
phosphorylation site under the regulatory control of Mechanistic Target of 
Rapamycin (mTOR) kinase (Lessmann et al., 2007). This, in turns, affects 
glucose metabolism and other processes that have significant impact on cell 
survival and cell cycle progression. A recent study by Sahir and co-workers 
have demonstrated the anti-proliferative action of a class of natural products, 
called ORPphillins, in tumor cells lacking p21 (Burgett et al., 2011). These 
compounds perturb the sub-cellular distribution and induce proteasomal 
degradation of ORP4L by occupying the same binding pocket of the ORD that 
accommodates 25HC. The implications of the critical role of ORP4L in Ca2+ 
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regulation, cell proliferation and survival, make it a potential target for anti-
cancer therapeutics. 
ORP8, a close homolog of ORP5, is known to anchor at the ER 
membrane and nuclear envelope by virtue of its carboxy-terminal 
transmembrane domain. By interacting with nucleoporin 62 (Nup62) 
(Béaslas et al., 2012), a component of the nuclear pore complex, ORP8 
regulates the nuclear transport which, in turn, impacts the functioning of 
SREBPs and LXRs. Likewise, physical interactions of ORP3 and ORP7 with 
the small GTPase R-Ras (Goldfinger et al., 2007; Lehto et al., 2008), are 
known to regulate signaling pathways associated with cell adhesion and 
migration, especially during malignant growth. Another member of the ORP 
family, ORP2 acts as a sterol receptor on cytoplasmic lipid droplets (LD) in 
adipocytes, and the ORP2-LD association is inhibited by 22HC, thereby 
indicating a role of this protein in neutral lipid metabolism (Hynynen et al., 
2009). 
 
1.3.6. Proposed mechanisms of monomeric exchange and bidirectional 
transport of lipids by ORPs 
Elucidation of the crystal structure of the yeast ORP named Osh4 (Im 
et al., 2005) and some recent mechanistic studies (de Saint-Jean et al., 2011; 
von Filseck et al., 2015a) have firmly established that Osh4 acts as a PIP-
sterol exchanger and transports ergosterol from the ER to trans-Golgi while 
bringing phosphoinositide, such as PI(4)P, back to the ER (Figure 7).  
Despite the absence of a PHD in Osh4, this bidirectional shuttling is achieved 
by the unique ability of the conserved sterol-binding/transfer domain (ORD) 
to effectively bind sterol as well as PI(4)P with similar affinity. This explains 
why Osh4 was able to rescue yeast strains with deleted Osh gene family (Beh 
and Rine, 2004). By exchanging sterol for PI(4)P, Osh4 was able to execute a 
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net transfer of sterol to the PM and Golgi, while the mutants with impaired 
ability to sequester PI(4)P, such as K336A and H143A/H144A, failed to do so 
(Im et al., 2005). 
The yeast ORPs that lack the VAP-A binding FFAT motif, such as 
Osh4, possess two membrane binding surfaces in their ORDs. The one near 
the mouth of the sterol-binding pocket is responsible for PI(4)P/sterol 
exchange. The site distal to the binding pocket binds certain PIPs, such as 
PI(4,5)P2 of a closely apposed acceptor membrane and regulates sterol 
extraction and transport from the donor membrane (Schulz et al., 2009). 
Osh4 is known to use the PI(4)P gradient between the Golgi and the ER, 
created by the ER-resident phosphoinositide phosphatase Sac1 and 
phosphatidylinositol 4-kinase Pik1 at the trans-Golgi, as an energy source for 
the transport of oxysterols against their concentration gradient (von Filseck 
et al., 2015a). Bankaitis and associates showed that the expression of Osh4 
was lethal for temperature-sensitive yeast strains lacking the essential gene 
encoding Sec14, a PI/PC transfer protein (Li et al., 2002). However, the 
deletion of Osh4 enabled the Sec14-deficient yeast strains to bypass their 
phenotype and survive. Discovery of the PI(4)P-sterol exchange mechanism 
by Antonny and co-workers now provides a fitting explanation for this 
observation (de Saint-Jean et al., 2011). The cell survival in OSH4-SEC14 
double deletion mutants is believed to be caused by the reduced backward 
transport of PI(4)P from the trans-Golgi to the ER. This results in the much-
needed preservation of the limiting amount of PI(4)P synthesized by Pik1 
when the anterograde transport of PI by Sec14 is compromised. 
Antonny’s group has also done extensive research on mammalian 
OSBP-mediated transfer of sterols and PIPs between donor and acceptor 
liposomes using Förster resonance energy transfer (FRET) (Mesmin et al., 
2013). Their work has established that mammalian OSBP can 
simultaneously interact with ER membrane protein VAP-A via its FFAT 
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motif and Golgi-specific PI(4)P and ADP-ribosylation factor 1 (Arf1)-bound 
GTP, via its PHD, causing membrane tethering at the MCS. This enables 
sterol transfer from ER to Golgi followed by back transfer of PI(4)P by the 
ORD (Figure 7). Finally, PI(4)P that is removed from the Golgi is hydrolyzed 
in the ER by the integral membrane phosphatase Sac1 (Kim et al., 2013).  
The energy released by the hydrolysis drives sterol transfer and allows 
negative feedback when PI(4)P becomes limiting.  
Figure 7: Proposed models of PIP-sterol exchange by ORPs. Single ORD in 
yeast Osh4, binds sterols and PI4P within the same pocket and facilitates exchange 
of these two ligands at membrane surfaces. This results in an overall flux of sterols 
from the ER to Golgi, and movement of PIP in the opposite direction. In humans and 
other mammals, OSBP localized at a MCS first binds ER-resident VAP-A by FFAT 
motif, followed by extraction of oxysterol from the ER (fully shaded ORD) and 
concomitant activation of PHD. Activated PHD binds PIP at the non-ER membranes 
and facilitates efflux of oxysterol from ER to target organelles (partially shaded 
ORD), such as the Golgi and PM while bringing back PIP to the ER.  
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It became apparent over a decade ago that localization of OSBP to 
various cellular organelles, such as the Golgi, ER and PM, is largely 
determined by two factors: the phosphorylation state of OSBP and the sterol 
content of cells (Storey et al., 1998). According to Ridgway and co-workers, 
depletion of cholesterol causes dephosphorylation of OSBP, which in turn 
localizes the protein at Golgi that harbours the phosphorylation machinery. 
In one of their recent studies, OSBP mutants mimicking the partial or 
complete phosphorylation state of the protein were designed to investigate 
the effects of phosphorylation on the sterol binding and transferability of 
OSBP (Goto et al., 2012). Two serine-rich motifs were identified to regulate 
OSBP activity at the ER. One was formed by Ser-381, -384, -387, -388 and -
391 (site 1 - located between the ORD and FFAT), and another was composed 
of Ser-192,195,200 (site 2 - located immediately upstream of the C-terminal 
end of the PHD). A site 1 phosphomimetic mutant, with Ser → Glu mutations 
at all five serine residues, demonstrated higher sterol binding and extraction, 
but diminished transfer activity compared to the wild-type protein. These 
mutations, however, did not affect the PI(4)P binding/transfer capability of 
OSBP. 
Despite the wealth of knowledge gathered about the mechanism of 
lipid transport by the members of the ORP protein family and their biological 
role, the precise nature of the association of ORPs with organellar 
membranes and the factors modulating such interactions requires further 
investigation. Given the abundance of in vitro fluorescent and radiolabel-
based assays with somewhat intricate and ambiguous design, a label-free 
analytical approach towards direct examination of protein-lipid bilayer 
interactions, using simple membrane systems, holds promising potential. 
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1.4. Research Objectives and Outline 
The primary goal of this project was to characterize the ability of 
OSBP to recognize membrane lipids by studying its association with surface-
immobilized PC bilayers using dual polarization interferometry (DPI) and 
monitoring ligand transfer with the help of a fluorescent sterol analog. My 
objectives included: 
 
Phase I 
i. Expressing, isolating and purifying recombinant OSBP using 
baculovirus expression vector system (BEVS) and conducting a series 
of membrane-binding assays on the DPI instrument by incorporating 
varying mol% of sterol ligands in the adsorbed bilayers. To investigate 
if (and how) wtOSBP interacted with the membranes based on the 
ligand concentration, I chose to study two sterols, namely, cholesterol 
and its most commonly used oxygenated derivative, 25-
hydroxycholesterol. 
 
ii. Performing the same assays, with adsorbed bilayers containing 
varying molar quantities of PI(4)P and validating the importance of 
PHD in PIP-recognition by the use of PHD mutant of OSBP (OSBP-
RR/EE). 
 
iii. Investigating the ability of OSBP to extract PI(4)P from immobilized 
membranes by comparing the behaviour of the wild-type protein with 
its ORD mutant (OSBP-HH/AA) that is known to possess unaltered 
PIP-recognition but impaired PIP-extraction capability.  
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Phase II 
iv. Studying the kinetics of monomeric sterol binding by wtOSBP and 
OSBP-HH/AA using 22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-
23,24-bisnor-5-cholen-3ß-ol – a fluorescent sterol analog abbreviated as 
22-NBD-cholesterol. 
 
v. Examining the transport of sterol by wtOSBP to vesicles containing 
PI(4)P by monitoring Förster resonance energy transfer (FRET) 
between 22-NBD-cholesterol and N-(lissamine rhodamine B sulfonyl)-
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (abbreviated as N-
Rhod-PE). 
 
The subsequent sections of this chapter provide a general overview of 
the technological approaches utilized in this research to meet the objectives 
listed above.  
 
1.5. Baculovirus Expression Vector System (BEVS) 
In vitro characterization and structure determination of proteins 
require their large-scale production in lab. In vivo expression systems follow 
traditional approaches wherein either prokaryotic or eukaryotic cells are 
transfected with DNA vectors engineered to carry the gene of interest and 
cultured in appropriate media to transcribe the gene and translate it into 
protein. This is typically followed by cell lysis, extraction and subsequent 
purification of the desired protein (Gräslund et al., 2008). On the other hand, 
in vitro (or cell-free) techniques utilize extracts of whole cells that are capable 
of transcription, translation and to some extent, post-translational 
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modifications of expressed proteins when supplemented with cofactors, 
nucleotides, the specific gene template and chaperones (Rosenblum and 
Cooperman, 2014).  
Each expression system offers selective advantages and disadvantages, 
particularly for the production of proteins larger than 100 kDa. Prokaryotic 
systems, such as E. coli, are known for rapid growth in culture and fast 
recombinant protein production, especially with the T7-based polymerase 
system. Expression of multi-domain eukaryotic proteins in E. coli renders 
them non-functional due to lack of cellular machinery required for proper 
protein folding and appropriate post-translational modifications. Also, the 
elevated yields make the proteins insoluble as inclusion bodies that are 
extremely cumbersome to recover and often require harsh treatments which 
pose the risk of protein denaturation. However, novel methods, involving 
milder solubilization techniques, have surfaced in recent years (Singh et al., 
2005, 2015). Mammalian host cells are the common choice for the production 
of larger eukaryotic proteins but this expression platform suffers from low 
yields, high production costs and is laborious and time-consuming. Cell-free 
techniques are also not sustainable for large scale production. 
In the mid-80s, insect baculoviruses became widely popular as novel 
vectors for heterologous expression of foreign genes in cultured insect cells 
and larvae (Clem and Passarelli, 2013). Owing to a host range restricted to 
lepidopteran insects (such as moths and butterflies), complete lack of 
pathogenicity in vertebrates and plants, capability of proper post-
translational modifications, growth in serum-free media and ease of scaling 
up, these viruses have become one of the most versatile and powerful 
eukaryotic vector systems for accurate recombinant gene expression. With 
the advent of specialized media, transfection reagents and chimeric vectors, 
BEVS technology has found several mainstream applications ranging from 
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structural and functional studies to development of vaccines and diagnostics 
(van Oers, 2011).  
 
1.5.1. Structural assembly of baculovirus 
The double-stranded, circular and supercoiled genome of a baculovirus 
spans approximately 80 – 180 kbp and is encapsulated in a large, rod-shaped 
capsid. Known to be one of the most prominent pathogens to obliterate 
vermian populations, these viruses have been identified particularly in 
insects of the order Lepidoptera (Clem and Passarelli, 2013). Baculovirus 
exists in two different forms of infectious particles (virions): budded virus 
(BV) and occluded/occlusion-derived virus (ODV). 
In infected larvae, budded virions are responsible for tissue-wide 
transmission of infection in vivo. The second-type of virions are occluded in 
large proteinaceous bodies called occlusion bodies (OBs), which are 
responsible for vertical transmission of infection from one infected larva to 
another. The ODVs are assembled entirely in the nucleus and, based on the 
number of virions packed in OBs, baculoviruses are broadly classified as 
granuloviruses, which are characterized by the presence of only one virion in 
each granular OB, or nucleopolyhedroviruses (NPVs), which produce large 
polyhedral OBs that carry hundreds of virions. In certain species of NPVs, 
ODVs can carry virions harbouring either single or a variable number of 
nucleocapsid units. Therefore, these NPVs are unofficially categorized into 
two subtypes, namely, single nucleopolyhedroviruses (SNPVs) and multiple 
nucleopolyhedroviruses (MNPVs). The two baculoviruses mostly widely used 
in the field of biotechnology as vectors for recombinant protein production are 
Autographa california (alfalfa looper) multiple nucleopolyhedroviruses 
(AcMNPVs) and Bombyx mori (silkworm) nucleopolyhedroviruses (BmNPVs) 
(van Oers, 2011; Clem and Passarelli, 2013). 
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1.5.2. Baculovirus life cycle 
Baculoviruses undergo both lytic and occlusive journeys during their 
life cycles. However, these events occur independently of each other over four 
distinct phases: immediate-early, delayed-early, late and very late. In the 
very beginning of the cycle, ODVs are ingested by insect larvae from plant 
surfaces. Upon entering the mid-gut of the feeding worm, the crystalline 
proteinaceous matrices of OBs dissolve in the alkaline milieu, thereby 
releasing BVs that attach, penetrate and fuse with the epithelial cells of 
microvilli. This marks the commencement of the early phase which is a 
preparatory phase for viral DNA replication. Following uncoating of viral 
particles, host gene expression is shut off and the viral immediate-early 
genes are transcribed by host-encoded RNA polymerase II (Rohrmann, 
2013c). This, in turn, initiates the transcription of delayed-early genes which 
encode proteins essential for DNA replication, such as DNA polymerase, 
helicase viral RNA polymerase, etc. (Rohrmann, 2013b). 
Late phase, also known as the virus structural phase, features viral 
DNA replication and expression of late genes that code for nucleocapsid and 
viral coat proteins. These proteins are responsible for virion assembly and 
budding. It is during this phase that new BVs are produced (Rohrmann, 
2013a). Their release by exocytosis and concomitant uptake by adjacent cells 
via endocytosis result in the horizontal spread of the infection. 
The very late phase is the viral occlusion protein phase wherein two 
major proteins, polyhedrin and P10, are produced in high quantity. 
Polyhedrin assembles to form the crystalline matrices of OBs within which 
virus particles synthesized in the nucleus are embedded to give rise to ODVs 
(Rohrmann, 2013d). The release of ODVs from the nucleus is facilitated by 
P10 and is followed by cell lysis that marks the end of the infection cycle. 
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Upon the subsequent death of the insect larvae, ODV polyhedra are released 
onto leaves and plant surfaces for vertical transmission of infection. 
 
1.5.3. Development of baculovirus expression vectors 
Direct cloning of a foreign gene, by means of a bacterial plasmid, into 
the 134 kbp AcMNPV genome is not a viable option. In 1983, Smith and 
Summers patented a method that involved homologous recombination 
between the baculovirus genome and the foreign gene contained in a transfer 
plasmid, under control of the P10 or polh promoter (Smith et al., 1983). The 
isolation of recombinant baculoviruses from the parental wild-types required 
sequential rounds of plaque purification, which was an extremely 
cumbersome process. In order to improve the success of recombination, Kitts 
et al. introduced linearized viral DNA in 1990 (Kitts et al., 1990). This 
technique resulted in ~30 % increase in the recovery of recombinants. 
The following decade witnessed several improvements, but a major 
breakthrough was achieved with the development of bacterial artificial 
chromosomes containing the AcMNPV genome (Luckow et al., 1993). Today, 
these vectors, termed bacmids, are introduced in E. coli (DH10β) and the 
eukaryotic gene of interest is incorporated into the bacmid by site-directed 
transposition using Tn7-recombinase (Figure 8). After PCR verification of 
the transgene, the recombinant bacmid is isolated to transfect insect cell 
lines. BV particles are propagated from the cultures and used to infect new 
cells. Several rounds of infection produce high-titre seed stocks of baculovirus 
for recombinant protein production. The baculovirus stocks, used in my work 
for the expression of OSBP and its mutants, were received as a gift from Dr. 
Neale Ridgway and his co-workers from Dalhousie University, Nova Scotia, 
Canada. 
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Figure 8: Strategy for creating recombinant baculovirus expression vector. 
An illustration of various steps involved in the production of recombinant 
baculovirus, using site-specific transposition, is shown here. The image is adapted 
from (Luckow et al., 1993) and Bac-to-Bac® Baculovirus Expression System, Life 
Technologies Corporation, 2015. 
 
1.5.4. Choice of host cell lines 
Among several established insect cell lines, Sf9 and Sf21 are the two 
most widely used cell lines that are highly susceptible to AcMNPV infection 
(Li et al., 1996; Kost et al., 2005; Schneider and Seifert, 2010). Originating 
from the ovarian tissues of Spodoptera frugiperda (fall armyworm) larvae, 
both these cells lines are highly adaptable to adherent as well as suspension 
cultures and can be distinctly identified by their enlarged and uniformly 
round morphology, enlarged nuclei, detachment from surface and inability to 
proliferate when infected by baculoviruses. Sf9 and Sf21 can be adapted to 
grow effectively in serum-free media at 27 ± 1 °C and generally do not require 
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antibiotic and CO2 supplementation. These favorable attributes make them 
the ideal host cells for use in BEVS technology. 
 
1.6. Dual Polarization Interferometry (DPI) 
Ever since the commercialization of Surface Plasmon Resonance (SPR) 
by Biacore® (GE Healthcare) in 1990 (Karlsson et al., 1991), the discipline of 
surface analytical chemistry has revolutionized research in the areas of 
biophysical, biomedical and pharmaceutical sciences. With advances in the 
developmental design of various biosensors, a plethora of investigations 
ranging from rapid screening of putative drug candidates to identification of 
harmful food toxins, have become a reality (Malhotra et al., 2014; Prével et 
al., 2014; Sahdeo et al., 2014). Today, surface techniques offer label-free 
(fluorescent, chemical or radiolabeled tags), user-friendly and real-time data 
collection. This enables the study of binding of small molecules to surface 
adsorbed biomolecules, protein-protein, protein-membrane and receptor-
ligand interactions, nucleic acid hybridization, kinetics of enzyme-substrate 
association and dissociation, protein crystal growth and more (Daghestani 
and Day, 2010; Boudjemline et al., 2011). One such technology, named Dual 
Polarization Interferometry (DPI), was commercially made available in 2000 
by Farfield Group Ltd (Swann et al., 2004). This approach provides a unique 
avenue for studying the solution-phase binding of a macromolecule (or small 
compound) with a physically immobilized biomolecular layer over the surface 
of a plain or chemically-derivatized chip. In addition, DPI provides an 
excellent platform for configuring parameters that define bilayer quality 
(such as appropriate thickness, refractive index, mass deposited per unit 
area, etc.) which aids in maintaining identical conditions for all protein 
adsorption studies and improves reproducibility and reliability of data 
acquisitions. 
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1.6.1. The working principle of DPI 
The operation of DPI is based on a pioneering experiment performed in 
1801 by an English physicist named Thomas Young, who demonstrated the 
interference of light waves. By allowing a beam of sunlight to pass through 
two narrowly placed slits in a sheet of paper, he noticed that a characteristic 
“dark and light pattern” was produced by the rays diffracting from the slits 
onto a screen held several meters away. In theory, when light waves from two 
coherent monochromatic sources interfere, they produce a pattern of 
alternate dark and light spots which is not visible in space since there is 
nothing substantially large in the air to reflect the light to our eyes. However, 
when projected onto a screen, this distinct pattern becomes visible. The 
locations where the light waves constructively reinforce each other appear 
abnormally bright and are referred as antinodes and the locations where the 
light waves destructively eliminate each other appear abnormally dark and 
are hence referred as nodes. Through his “double slit” experiment, Young 
derived an equation for calculating the wavelength of the light originating 
from the source and resurrected the century-old theory that light has a 
wavelike nature. 
 
1.6.2. Overview of DPI system components and data acquisition 
The DPI instrument derives its light source from a helium-neon laser 
that emits at a constant wavelength of 632.8 nm. The emitted light passes 
through a polarizer and is fed into a biosensor that consists of two 
waveguides stacked on top of each other with a layer of cladding sandwiched 
between them (Figure 9). The setup mimics Young’s “double slit”. The 
waveguides are made of silicon oxynitride and the light waves entering them 
remain coherent (with constant phase difference and frequency) and confined 
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Figure 9: Operating principle of dual polarization interferometry. A 
schematic diagram of DPI instrument is shown. A laser-generated monochromatic 
light passes through a polarizer (not shown for clarity) and splits into two coherent 
beams upon entering the biosensor. The light waves diffracting from the biosensor 
waveguides produce a characteristic interference pattern. Adsorption of 
biomolecules on the sensing surface and subsequent changes in the refractive index 
cause phase shifts in the double polarizations (TM and TE) of the interfering light 
waves. These signals are then resolved by the instrument into physical variables 
depending on the applied algorithm (Swann et al., 2004). 
 
Upon adsorption of a biomolecular layer (for example, a phospholipid 
bilayer), the velocity of light traveling through the top waveguide changes 
and acts as a “sensor” while the one traveling through the bottom waveguide 
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remains unaltered and hence, serves as a “reference”. The emergent light 
waves, no longer in phase, diffract and interfere with each other at “far field”, 
thereby producing a series of dark and light fringes. The spatial separation of 
nodes and antinodes is defined by the phase difference between the two 
interfering light waves emerging from the ends of the waveguides. 
The position of the interference fringes shifts when the light traveling 
through the top waveguide changes further due to addition and interaction of 
proteins to the immobilized bilayer. These movements are captured by a 
camera and the changes in the transverse magnetic (TM) phase are deduced 
from the distances moved by the fringes. A second polarization of the light, 
namely transverse electric (TE), is directed at an angle perpendicular to the 
TM and thus provides an independent second measurement of protein 
association/dissociation. The DPI technology is capable of translating the raw 
data obtained from these two measurements into comprehensible physical 
variables such as thickness, specific mass, and density of the protein layer 
(Swann et al., 2004). 
 
1.7. Förster resonance energy transfer (FRET) 
A number of cholesterol analogs are used to study and visualize the 
distribution of sterols in intracellular membranes. While most of these 
analogs are fluorophore-labeled (such as BODIPY, NBD, dansyl, etc.), there 
are some variants of cholesterol which carry conjugated double bonds within 
the steroid ring system of cholesterol. This makes them fluoresce in the near 
UV-region of the spectrum (Maxfield and Wüstner, 2012). Some examples are 
dehydroergosterol (DHE) and cholestatrienol (CTL). The chemical structures 
of these intrinsically fluorescent sterols closely resemble that of cholesterol 
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and therefore do not perturb ligand binding to the ORD, unlike the bulky 
fluorescent groups such as BODIPY and NBD (Figure 10).  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Structures of commercially available fluorescent cholesterol 
analogs. Fluorescent cholesterol reporters commonly used for cholesterol 
binding/transfer assays: DHE, CTL (cholesta-5,7,9(11)-trien-3β-ol), 6-dansyl-
cholesterol, 22-NBD-cholesterol (22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-
23,24-bisnorchol-5-en-3ß-ol), and 23-BODIPY-cholesterol (23-(4,4-difluoro-1,3,5,7-
tetramethyl-4-bora-3a,4a-diazas-indacen-8-yl)-24-norchol-5-en-3β-ol). 
  
DHE and CTL, however, suffer from the disadvantage of low 
fluorescence brightness and poor environmental sensitivity (Chong and 
Thompson, 1986; Schroeder et al., 1988; Hyslop et al., 1990). NBD groups are 
Dehydroergosterol (DHE) Cholestatrienol (CTL) 
6-Dansyl-cholesterol 
23-BODIPY-cholesterol 22-NDB-cholesterol 
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known to display a high degree of environment sensitivity (Haldar and 
Chattopadhyay, 2013). They are usually characterized by a markedly longer 
fluorescence lifetime and higher intensity of fluorescent emission in 
hydrophobic media such as membranes as compared to a polar surrounding. 
NBD-labeled cholesterol analogs, especially the alkyl side-chain substituted 
ones, tend to localize inside the membrane’s interior or the hydrophobic 
pocket of LTPs, such as ORPs.  
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Figure 11: Chemical structures and spectral overlap of 22-NBD-cholesterol 
and N-Rhod-PE. The chemical structures of 22-NBD-cholesterol and N-Rhod-PE 
are shown. The region in red represents the NBD fluorophore and the one in blue 
represents the LissamineTM Rhodamine B fluorophore. Scans of 22-NBD-cholesterol 
and N-Rhod-PE fluorescence from 300 – 700 nm are shown here. The overlapping 
region of the emission spectrum of NBD and the excitation spectrum of Rhodamine 
is represented by the shaded region. The arrows indicate the excitation wavelength 
(red) and emission wavelength (blue) used for FRET-based ligand transfer assay. 
22-NDB-cholesterol 
(FRET donor) 
N-Rhod-PE 
(FRET acceptor) 
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Förster resonance energy transfer (FRET) is a physical phenomenon 
wherein a donor fluorophore absorbs energy of incident photons and transfers 
the energy of its excited state to a nearby acceptor fluorophore. As a result, 
the donor fluorescence gets quenched along with a decrease in the lifetime of 
its excitation and a concomitant increase in the intensity of acceptor 
fluorescence, which always emits at a longer wavelength than that of the 
donor (Hussain, 2012). The fluorescence intensity decreases with an increase 
in the average spatial separation of the probes (Johnson and Spence, 2010). 
The excitation and emission spectra of a FRET donor-acceptor pair is shown 
in Figure 11. 
Several molecular probes are commercially available today for FRET-
based analysis of ligand transfer by proteins (de Saint-Jean et al., 2011; 
Mesmin et al., 2013) and monitoring protein-protein or protein-lipid 
interactions (Margineanu et al., 2016). The choice of the FRET pair, 
therefore, completely hinges on the nature of the system to be investigated 
and the behaviour of the probe molecule in the environment in which the 
desired assay is to be performed. For this project, I chose to use the NBD-
Rhodamine pair. FRET occurs when OSBP-bound 22-NBD-cholesterol is 
delivered into the membrane bilayer of an acceptor vesicle containing N-
Rhodamine-phosphatidylethanolamine. The rate of transfer is typically 
monitored by recording over time the intensity of rhodamine emission at 
~581 nm, a consequence of energy transfer when NBD is excited at ~469 nm.  
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Chapter 2 
METHODOLOGY 
This section gives an overview of the experimental journey of my research 
beginning with the heterologous expression of OSBP and its mutants in insect 
cell lines, followed by their isolation, purification, biochemical 
characterization, ultimately culminating in the study of OSBP’s ability to 
recognize, bind and transfer specific sterol and phosphoinositide species in 
solution as well as artificial phospholipid membranes. The protocols and 
materials utilized for the development of analytical assays have been 
documented in this chapter, along with the selection of mathematical models 
to explain the ligand-modulated lipid association and dissociation of OSBP, 
applicable for both label-free and fluorophore-based studies. 
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2.1. Culture of host cells (Sf21) 
Sf21 (Life Technologies, Burlington, ON), a suitable host cell line 
developed from the ovaries of fall armyworm (Spodoptera frugiperda), was 
grown as a stable monolayer in Gibco® Sf-900 III serum-free medium (Life 
Technologies, Burlington, ON) supplemented with 5 % FBS (Sigma-Aldrich 
Canada, Oakville, ON) at 27 ± 1 °C in a non-humidified, ambient air-
regulated incubator. The following antibiotics were added to prevent 
contamination by gram-positive and gram-negative bacteria as well as fungal 
infections: 100 U/mL penicillin, 100 µg/mL streptomycin, and 0.25 µg/mL 
amphotericin B deoxycholate (Sigma-Aldrich Canada, Oakville, ON). When 
the culture reached ~90 % confluency, cells were passaged at a split ratio of 
1:5 in T-25 tissue culture flasks every 72 – 96 h. The seeding density 
was ~3 × 104 viable cells/cm2. The confluency and viability were routinely 
monitored by observations under a light microscope and dye-exclusion assay, 
respectively. A 0.4% buffered solution of trypan blue (Sigma-Aldrich Canada, 
Oakville, ON) enabled direct identification and enumeration of live 
(unstained) and dead (blue) cells in Sf21 cultures.  
Cell densities were measured by an improved Neubauer counting 
chamber and the values were routinely logged prior to the propagation of a 
new generation, according to the format given in Figure 12. Cultures were 
discarded after passaging for 20 – 25 generations and new cultures were 
started with freshly-thawed cells. In order to develop master stocks of cells 
for future use, healthy-growing Sf21 cells, showing > 90 % viability, were 
suspended in freezing medium, which was prepared by mixing conditioned 
and fresh growth media in 1:1 ratio, containing 10 % FBS and 7.5 % dimethyl 
sulfoxide (DMSO; Life Technologies, Burlington, ON). Cells were then 
aliquoted in 1.5 mL volumes, at a density of 1 × 107 cells/mL, in cryo-vials. 
The vials were cooled at a standard rate of -1 °C/min in Mr. Frosty™ freezing 
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container (Thermo Fisher Scientific, Mississauga, ON) before storing in liquid 
nitrogen vapor phase (-140 to -180 °C). 
Passage 
Number 
Date 
Cell Density 
(cells/mL or 
cells/cm2) 
Viability 
(% of total 
# of cells) 
Comments 
(split ratio, cell morphology, 
media lot #, etc.) 
1     
2     
…     
Figure 12: Format of log for maintaining Sf21 cell line. A typical format of log, 
maintained regularly during the propagation of Sf21 cell line, is shown. The date of 
initiation of culture from a frozen master stock, initial cell density, and net 
composition of the working media (including amounts of added antibiotics and 
serum) were also recorded. 
 
2.2. Expression of OSBP using recombinant baculoviruses 
After 3 – 4 passages of monolayers, the cells were transferred to 
shaker flasks at a seeding density of ~5 × 105 cells/mL and incubated at 27 ± 
1 °C and 130 rpm in a non-humidified, ambient air-regulated incubator. They 
adapted to suspension after 2 generations. The culture, while in its 
logarithmic growth phase, was infected with AcMNPV baculovirus at a 
density of 1.8 × 106 cells/mL and desired multiplicity of infection (MOI). The 
baculovirus constructs harbouring cDNA of C-terminal 6×His-tagged 
wtOSBP, OSBP-HH/AA and OSBP-RR/EE mutants were generously gifted by 
Dr. Neale Ridgway (Dalhousie University, Halifax, NS). The infected cells 
were incubated in the dark under the same growth conditions as mentioned 
above. The culture was monitored for signs of infection, such as increased 
diameter and larger nuclei, over a period of 48 – 72 h. In light of the 
knowledge that baculoviruses possess lytic capabilities, it was considered 
extremely important to optimize the MOI and monitor cell viability during 
the infection period. It helped to ensure that cells were harvested before they 
were rendered non-viable due to prolonged infection. After infecting two 
Chapter 2 | METHODOLOGY 
 
Page | 48  
batches of Sf21 cultures, one for 72 h at an MOI of 0.1 and another for 48 h at 
an MOI of 0.2, protein expression levels were compared (see Results, 
Section 3.1.3) and based on the results, MOI of 0.2 was used for subsequent 
expressions. 
 
2.3. Isolation of OSBP by IMAC 
Sf21 cells were pelleted at 10,000 × g and frozen overnight at -80 ° C, 
48 – 72 h post-infection. They were subjected to mechanical disruption at 4 °C 
by passing through 18 G and 23 G needles and homogenizing by sonication in 
lysis buffer: 20 mM Tris-HCl (pH = 7.4), 150 mM NaCl, and 1% Triton X-100. 
10 mL lysis buffer was used per g of cell pellet. In order to prevent unwanted 
proteolysis, a suitable EDTA-free cocktail of inhibitors for serine, cysteine 
and aspartic proteases (Roche Diagnostics, Laval, QC) was used along with 
DNase I (Fisher Scientific, Ottawa, ON) for removal of nucleic acids. The 
extracted intracellular proteins were subjected to immobilized metal affinity 
chromatography (IMAC) for isolation of recombinant 6×His-tagged OSBP.  
The stationary phase was made up of Profinity™ IMAC resin (Bio-Rad 
Laboratories Canada, Mississauga, ON) that contained Bio-Rad’s proprietary 
UNOsphere™ beads coupled with an iminodiacetic acid (IDA) linker. Prior to 
use, the resin was coupled with a divalent metal cation (in this case, Co2+) by 
incubating in 2 M CoCl2 (pH = 4.6). The tridentate IDA ligand gives rise to an 
octahedral metal coordination complex with imidazole sidechains of the 
polyhistidine tag (Figure 13). This architecture allowed strong and highly 
selective binding of recombinant 6×His-OSBP and its mutants. Therefore, the 
use of EDTA was avoided because of its known ability to chelate with the 
Co2+ ions and disrupt binding of the polyhistidine-tagged proteins to the 
IMAC column. The clarified lysate was spun down at 40,000 × g and the 
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supernatant was incubated overnight at 4 °C with Co2+-IDA resin; this was 
packed into a high-resolution Bio-Scale™ MT column (Bio-Rad Laboratories 
Canada, Mississauga, ON). The chromatography process was executed in a 
semi-automated fashion on the BioLogic DuoFlow™ FPLC system (Bio-Rad 
Laboratories Canada, Mississauga, ON). 
 
Figure 13: Capturing of His-tagged proteins. The underlying chemistry of 
capturing polyhistidine-tagged protein by cobalt-iminodiacetic acid (Co2+-IDA) resin 
during immobilized metal affinity chromatography (IMAC) is shown. The imidazole 
groups of His form an octahedral coordination complex with Co2+ along with carboxyl 
groups and nitrogen atom of IDA linker. 
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During the operation, the IMAC column was first rinsed with the 
running buffer: 50 mM NaH2PO4 and 300 mM NaCl (pH = 7.4) at 12 – 15 psi 
and a flow rate of 4 mL/min. Proteins containing variable number of His 
residues bound with the resin via weak interactions and were effectively 
removed by a wash with the running buffer containing 20 mM imidazole. 
Recombinant OSBP was eluted as 4 mL fractions under the same flow 
conditions with elution buffer: 50 mM NaH2PO4, 300 mM NaCl and 200 mM 
imidazole (pH = 7.4). Compared to a gravity-based chromatography setup, 
semi-automated low-pressure FPLC system provided several advantages, 
such as, reduced time of operation, increase in protein yield, ease of scaling-
up, and flexibility of fine-tuning the process by adjusting buffer compositions 
in real-time. A summary of a batch purification of wtOSBP using IMAC-
FPLC has been provided in the Results, Section 3.1.2 (Figure 17). 
 
2.4. Quantification of OSBP 
OSBP was quantified by the Bradford protein quantification method 
(Bradford, 1976). 50 µL of purified OSBP was incubated at room temperature 
with a 1 mL mixture of 50 % (w/v) Coomassie Brilliant Blue G-250 dye, 25 % 
(v/v) methanol and 50 % (v/v) phosphoric acid, commonly known as the 
Bradford reagent (Sigma-Aldrich Canada, Oakville, ON). The absorbance of 
the mixture at 595 nm was measured by a UV-Vis spectrophotometer and its 
concentration was determined by the help of a standard curve obtained by 
plotting the absorbance values of a series of BSA standards against their pre-
determined concentrations. Protein concentration estimated using the 
Bradford method was cross-checked with the values calculated by the Beer’s 
Law using the relationship:  
A = εcl          (eq. 1) 
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In this equation, A stands for absorbance of the protein solution 
measured at 280 nm, ε represents molar extinction coefficient of OSBP at 280 
nm (122270 M-1 cm-1), c denotes concentration of protein in the sample, and l 
defines the length of the path traveled by the light (1 cm, for the cuvettes 
used in this study). 
 
2.5. Molecular weight analysis of OSBP by SDS-PAGE 
The molecular weight of purified OSBP was confirmed by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Based on the 
estimated protein concentrations, approximately 3 – 5 µg of crude and 
clarified cell lysate, unbound protein fraction from IMAC and purified protein 
fraction(s) were incubated for 5 min at 90 °C with the Laemmli sample 
buffer: 50 mM Tris-HCl, 2 % SDS, 6 % glycerol, 1 % β-mercaptoethanol, and 
0.004 % bromophenol blue (pH = 6.8) and loaded onto a precast Mini-
PROTEAN® TGX Stain-Free™ 10 % polyacrylamide gel (Bio-Rad 
Laboratories Canada, Mississauga, ON). Alternatively, hand-cast gels were 
also used from time to time for routine analyses. The resolving gel was 
prepared by mixing the following constituents in volumes determined by the 
size and quantity of the gels to be cast: 40% aqueous soultion of 
acrylamide/bis-acrylamide, resolving buffer: 1.5 M Tris-HCl (pH 8.8), 10% 
(w/v) sodium dodecyl sulfate (SDS), freshly prepared solution of 10% (w/v) 
ammonium persulfate (APS) and tetramethylethylenediamine (TEMED). For 
preparing the stacking gel, the resolving buffer was replaced by the stacking 
buffer: 0.5 M Tris-HCl (pH 6.8) in the above recipe. 
The protein samples, denatured by the SDS in the Laemmli buffer and 
bearing uniform charge-to-mass ratio, were separated based on size by 
applying a voltage of 150 mV across the gel submerged in the electrophoresis 
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tank filled with the SDS-PAGE running buffer: 25 mM Tris, 192 mM glycine, 
0.1 % SDS (pH = 8.3) for 1 – 1.5 h. The protein bands in the stain-free gels 
were visualized directly by the Gel Doc™ EZ gel documentation system (Bio-
Rad Laboratories Canada, Mississauga, ON) while the hand-cast gels were 
stained overnight with a 9:1 mixture of ProtoStain™ colloidal Coomassie 
Brilliant Blue G-250 (National Diagnostics, Atlanta, GA) and ethanol 
followed by de-staining with distilled water. The molecular weight of OSBP 
was determined by comparing the resolved bands with Precision Plus 
Protein™ standards (Bio-Rad Laboratories Canada, Mississauga, ON). 
 
2.6. Immunodetection of OSBP by Western blot 
Identity of OSBP in the eluted fractions from IMAC was further 
confirmed by Western blot. Unstained polyacrylamide gel from SDS-PAGE 
and nitrocellulose or polyvinylidene fluoride (PVDF) membrane were primed 
by soaking in transfer buffer: 25 mM Tris, 192 mM glycine, and 20 % 
methanol (pH = 8.3) for 10 min (Towbin et al., 1979). The gel was sandwiched 
with the membrane, between filter papers soaked in transfer buffer. The 
cassette was left overnight at room temperature for efficient protein transfer.  
Next day, the vacant sites on the membrane were blocked to prevent 
nonspecific antibody binding using TBST blocking buffer: 10 % nonfat dry 
milk, 10 mM Tris, 150 mM NaCl, 0.05 % Tween® 20, (pH = 8) and rinsed with 
TBST wash buffer: 10 mM Tris, 150 mM NaCl, and 0.05 % Tween® 20 (pH = 
8). The membrane was then probed with mouse anti-OSBP monoclonal IgG1 
primary antibody (dilution 1:200; Santa Cruz Biotechnology, Dallas, TX) for 1 
h followed by rinsing with TBST wash buffer and incubation with anti-mouse 
IgG-horseradish peroxidase (HRP) conjugate secondary antibody (dilution 
1:2500; Promega, Sunnyvale, CA) for 30 min. After a final rinsing with TBST 
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wash buffer, OSBP was visualized as distinct band(s) by exposing the 
membrane to liquid HRP-substrate 3,3′,5,5′-tetramethylbenzidine (TMB; 
Sigma-Aldrich Canada, Oakville, ON) for 3 – 5 min. 
 
2.7. Preparation and size-determination of unilamellar 
lipid vesicles 
The following phospholipids and sterols were used for the membrane-
binding assays using DPI: 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), L-α-phosphatidylinositol-4-phosphate (PI(4)P; porcine brain), 
cholesterol (ovine wool) and 25-hydroxycholesterol (Avanti Polar Lipids, 
Alabaster, AL). The structures of the unlabeled phospholipids used in this 
project are shown in Figure 14. The volatile organic solvents (primarily 
chloroform) of the commercial lipid stocks were removed by a stream of 
nitrogen gas. The residual solvents were further dried in a high-vacuum 
evaporator for 1 – 2 h. 
 
 
Figure 14: Chemical structures of phospholipids. (A) DOPC and (B) PI(4)P 
were used in the DPI-based membrane binding assays. 
 
For DPI-based assays, DOPC with varying mol% of PI(4)P, cholesterol 
and 25-hydroxycholesterol were reconstituted overnight at 4 °C in DPI 
(A) 
(B) 
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running buffer: 10 mM K2HPO4 and 137 mM NaCl (pH = 7.4). Large 
unilamellar vesicles (LUVs) were freshly prepared in glass vials immediately 
before experimentation by means of repeated extrusion through 
polycarbonate membrane (pore size = 100 nm; Avestin, Ottawa, ON) using a 
mini syringe-extruder (Avanti Polar Lipids, Alabaster, AL). Lipid samples 
were passed through the membrane for at least 15 – 20 times to ensure 
formation of uniform vesicles. The final lipid concentration of the extruded 
LUVs was 0.5 mM. 
For FRET-based transfer assays, small unilamellar vesicles (SUVs) 
were prepared that contained DOPC with 3 mol% FRET-acceptor N-
(lissamine rhodamine B sulfonyl)-1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (Avanti Polar Lipids, Alabaster, AL), commonly 
abbreviated as N-Rhod-PE. For some experiments, these vesicles also 
contained 4 mol% PI(4)P. Dried lipids were re-suspended overnight in DPI 
running buffer, sonicated using a probe sonicator at an amplitude of 30 % for 
10 – 15 min until the suspension became homogeneous, and repeatedly 
extruded through membrane with pore size of 50 nm, as explained above. The 
SUVs were prepared at a concentration of 0.2 mM. The sizes of both type of 
vesicles were determined by a DynaPro-99-E-50 dynamic light scattering 
(DLS) spectrophotometer (Protein Solutions, Lakewood, NJ). 
 
2.8. Dual polarization interferometry (DPI) 
Purified OSBP, originally stored in IMAC elution buffer, was 
reconstituted in DPI running buffer using Econo-Pac® 10DG desalting 
gravity-flow columns (Bio-Rad Laboratories Canada, Mississauga, ON). 
Approximately 3 mL of protein sample was loaded on the column and eluted 
in 4 mL of DPI buffer. 
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Membrane-binding assays were performed to study the interaction of 
wtOSBP and its mutants with planar lipid bilayers containing DOPC with 
various ligands. The instrument used for this purpose, named AnaLight® 
Bio200 dual polarization interferometer (Farfield Group and Biolin Scientific, 
Stockholm, Sweden), was first equilibrated with DPI running buffer for 1 h. 
An unmodified silicon oxynitride sensor chip (AnaChip™ FB 80; Farfield 
Group and Biolin Scientific, Stockholm, Sweden) was then installed and the 
regions on the chip surface that provided clear pattern of interference fringes 
were selected for experimental observations. All reagents and buffers used 
during the assay were degassed for at least 30 min prior to use. The 
experiments were performed at 20 °C. 
 
Figure 15: Illustration of events occurring on DPI sensor during a 
membrane-binding assay. A simple depiction of vesicle immobilization and 
bilayer formation on the surface of a DPI sensor is shown here. The injected protein 
interacts with the bilayer and alters the refractive index of the medium, which is 
recorded in real-time as a phase shift of dual polarized light. 
 
At first, the new chip was calibrated by injecting 80% ethanol and 
ultrapure water. This was followed by an injection of ~800 µL of desired 
LUVs with lipid concentration of 0.5 mM. The vesicles were allowed to 
immobilize and form bilayers on the chip surface. The flow rate was set to 25 
µL/min and the injection of vesicles was performed for 8 min. Unilamellar 
vesicles are known to adsorb from the bulk solution onto the surface of solid 
support (in this case, the sensor chip) and spontaneously fuse with each other 
during the early part of the bilayer formation process where only vesicles 
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populate the surface. The fused vesicles begin to rupture at a critical surface 
coverage resulting in the co-existence of bilayer islands, intact vesicles and 
bare surface. Finally, a consistent planar supported lipid bilayer (SLB) is 
formed which covers the entire surface (Mashaghi et al., 2008) (Figure 15). 
SLB formation depends on the vesicular lipid composition and other factors 
that include charge, roughness, and cleanliness of the surface as well as pH, 
osmotic strength and ionic strength of the solution in which the vesicles are 
prepared (Castellana and Cremer, 2006). 
After a stable bilayer was formed with a thickness of 4 – 5 nm, a quick 
injection of DPI buffer was performed (100 µL/min for 2 min) to remove 
excess lipids. Approximately 600 – 700 µL of required concentration of OSBP 
was then fed into the system at flow conditions identical to that used for lipid 
injection. The signal obtained from the DPI upon injecting vesicles and 
protein (Results, Section 3.2, Figure 20, Steps # 3 and 4), in the form of 
transverse magnetic (TM) and transverse electric (TE) phase shifts, was 
resolved and the specific mass of OSBP adsorbed/mm2 of bilayer was 
calculated by AnaLight® Explorer software (Farfield Group and Biolin 
Scientific, Stockholm, Sweden). These values were plotted against time to 
obtain real-time association curves. To gain a better understanding of OSBP’s 
binding behaviour with membranes containing PI(4)P or sterols, the 
maximum specific mass of bound OSBP was also determined using GraphPad 
Prism® (ver. 6.0; GraphPad Software, La Jolla, CA) and plotted either as a 
function of mol% of ligand in the immobilized phospholipid bilayer or as a 
function of protein concentration, in order to obtain saturation binding 
curves. 
At the end of protein injection, the surface-adsorbed lipid-protein layer 
was disintegrated by injecting 1 mL of each 2 % Hellmanex® cleaning 
concentrate (Hellma Canada Limited, Markham, ON) and 2 % SDS, 
successively, at a flow rate of 100 µL/min. The sensor was regenerated by 
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injecting 80 % ethanol at the same flow rate. A typical response obtained 
from the DPI instrument during an experiment is shown in the Results, 
Section 3.2 (Figure 20). 
 
2.9. PI(4)P immunodetection assay 
In order to test the hypothesis that wtOSBP extracted PI(4)P from 
phospholipid bilayers immobilized on the surface of the DPI sensor, it was 
necessary to detect PI(4)P in the protein fractions dissociating from these 
bilayers. To achieve this goal, wtOSBP, which interacted with bilayers 
containing either DOPC or DOPC + varying mol% of PI(4)P, was collected 
from the effluent flowing out of the DPI instrument. The protein sample was 
lyophilized in 1 mL fractions overnight at -80 °C. In order to dissolve PI(4)P, 
a 2:1:0.8 mixture of CH3OH:CHCl3:H2O was added to the freeze-dried 
samples and vortexed extensively. After overnight incubation, the extracted 
PI(4)P was blotted on Amersham Hybond™ nitrocellulose membrane (GE 
Healthcare Canada, Mississauga, ON). The membrane was blocked with 
blocking buffer, probed with anti-PI(4)P mouse monoclonal IgM (1:500; 
Echelon Biosciences, Salt Lake City, UT) followed by goat anti-mouse IgM-
HRP conjugate secondary antibody (1:1000; Santa Cruz Biotechnology, 
Dallas, TX), and visualized by adding TMB, as described in Section 2.6. 
Blots of lipid standards, containing 0.1, 1, 10 and 100 pmol of PI(4)P, were 
also assayed to provide a reference for comparison of signal intensities of 
experimental samples. DPI buffer, devoid of any protein, was injected over 
lipid bilayers and collected from the DPI effluent to serve as a negative 
control. 
An alternate assay was developed to circumvent some technical 
difficulties with the method indicated above (see Results, Section 3.3.5, for 
details). In this, after performing an injection of wtOSBP (or DPI buffer as 
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negative control), the chip was removed from the instrument and PI(4)P-
containing DOPC bilayer was solubilized overnight in a 2:1:0.8 mixture of 
CH3OH:CHCl3:H2O. The samples were blotted and probed with anti-PI(4)P 
antibody, as explained above. The aim was to observe a loss-of-PI(4)P signal 
in lipids extracted from the bilayers that were exposed to wtOSBP, in 
comparison to the control. PI(4)P standards ranged from 10 nmol to 1 pmol.  
 
2.10. Quantification of fluorescent lipid analogs 
22-NBD-cholesterol (Setareh Biotech LLC, Eugene, OR) is a 
commercially available fluorescent analog of cholesterol that has a peak 
excitation wavelength (λmax) of 469 nm. Serially diluted stocks of this 
compound were prepared in methanol and the absorption spectra were 
acquired by a UV spectrophotometer. The molar extinction coefficient of 22-
NBD-cholesterol in methanol is 21,000 M-1 cm-1 (Johnson and Spence, 2010). 
Using this and the measured A469 values, the concentration of the 
fluorescent-sterol was determined by Beer’s Law (see eq. 1 in Section 2.4). 
The fluorescent phospholipid analog N-Rhod-PE (Avanti Polar Lipids, 
Alabaster, AL) is known to have a peak excitation wavelength (λmax) of 560 
nm and a molar extinction coefficient of 75,000 M-1 cm-1 in methanol (Johnson 
and Spence, 2010). This compound was quantified by the same approach as 
outlined above for 22-NBD-chlesterol. The chemical structures of these lipid 
analogs are displayed in Figure 11. 
 
2.11. Binding assay of 22-NBD-cholesterol 
The ability of wtOSBP and OSBP-HH/AA to bind monomeric sterol 
was examined by means of 22-NBD-cholesterol binding assay. For this, each 
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protein was prepared in DPI buffer at a concentration of 200 nM and a total 
volume of 3 mL was aliquoted in a quartz cuvette (Hellma Canada Limited, 
Markham, ON). The sample was then titrated by serial additions of fixed 
(initially) or incremental (during later part of the assay) volumes of 22-NBD-
cholesterol stocks (25 µM and 100 µM for this assay) prepared in methanol. 
After each addition, the protein-ligand mixture was allowed to equilibrate at 
room temperature for 10 min on a tube rotator. After exciting the fluorophore 
at 469 nm, fluorescence emission from NBD was scanned between 515 and 
550 nm using PTI QuantaMaster™ QM-2001-4 spectrofluorometer (Horiba 
Canada Inc., London, ON). To prevent protein denaturation and loss of 
function, the total concentration of methanol was kept under 1 % (v/v). 
Fluorescence intensity at the wavelength of maximum emission (λem), 
i.e.  537 nm, was recorded at each step and plotted against the total 
concentration of 22-NBD-cholesterol added, to obtain a binding curve. The 
data were normalized and fitted to a one-site specific binding model in 
GraphPad Prism® (ver. 6.0; GraphPad Software, La Jolla, CA) according to 
the following equation: 
 
Y =
	


            (eq. 2) 
 
In the above equation, Y denotes specific binding; Bmax is the maximum 
specific binding (maximum in case of normalized data), in the same units as 
Y; X represents concentration of fluorescent ligand added to the protein 
sample; and Kd denotes equilibrium binding constant, in the same units as X. 
Kd values provided an insight into the affinity of the fluorescent cholesterol 
analog for OSBP and its mutant. The assay was performed with bovine 
serum albumin (BSA), in place of OSBP, as a control. 
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2.12. Competitive binding assays of 22-NBD-cholesterol 
The ability of natural sterols to competitively replace 22-NBD-
cholesterol from the binding pocket of wtOSBP and OSBP-HH/AA was 
examined. For this, 3 mL of 200 nM protein in DPI buffer was saturated with 
500 nM 22-NBD-cholesterol (prepared in methanol). After 4 h of equilibration 
on a tube rotator at room temperature, the sample was titrated by serial 
additions of fixed (initially) or incremental (during later part of the assay) 
volumes of either cholesterol or 25-hydroxycholesterol stock (25 µM and 100 
µM for this assay) prepared in isopropanol or ethanol, respectively. The 
remainder of the experiment was performed as outlined in Section 2.11. 
Fluorescence intensity was plotted as a function of concentration of 
competing ligand, in this case, cholesterol or 25-hydroxycholesterol, to obtain 
a competitive binding curve. The data were normalized and the ligand 
concentration was log-transformed to fit a one-site competitive binding model 
in GraphPad Prism® (ver. 6.0; GraphPad Software, La Jolla, CA) according to 
the following equation: 
 
Y = min + 

( !"#$%)
          (eq. 3) 
 
In the above equation, Y denotes total binding; max and min represent 
maximum binding in the absence of unlabeled ligand and non-specific 
binding, respectively, in the same units as Y; X is the log concentration of 
unlabeled ligand added to the protein sample; and EC50 denotes the 
concentration of competitor that results in binding half-way between max 
and min, in the same units as X. EC50 values provided an insight into the 
efficacy of natural sterols in displacing 22-NBD-cholesterol from the binding 
pocket of OSBP. The assay was performed on bovine serum albumin (BSA) as 
a control. 
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2.13. OSBP-mediated sterol transfer by FRET 
The ability of OSBP to transfer ORD-bound sterol ligand to an acceptor 
vesicle was examined by measuring the rate of Förster resonance energy 
transfer (FRET) between OSBP-bound 22-NBD-cholesterol and vesicle-
resident N-Rhod-PE. SUVs used for this purpose contained DOPC and 3 
mol% N-Rhod-PE. They were either devoid of PI(4)P (control) or harboured 4 
mol% PI(4)P (experimental). At first, 4 µM protein (both wild-type and OSBP-
HH/AA) was equilibrated with 0.8 µM 22-NDB-cholesterol for 30 min at room 
temperature on a rotator. The 5:1 protein:ligand ratio was chosen to allow 
complete binding of all ligand molecules to the protein prior to the transfer 
assay and to ensure high starting fluorescence count from 22-NBD-
cholesterol. At the end of the incubation period, equal volumes of protein-
ligand complex and 0.2 mM acceptor SUVs were mixed together in a quartz 
cuvette. The mixing was performed by a stop-flow apparatus attached to a 
PTI QuantaMaster™ QM-2001-4 spectrofluorometer (Horiba Canada Inc., 
London, ON). A 50-fold molar excess of SUVs, compared to protein, was used 
to ensure delivery of sufficient amounts of 22-NBD-cholesterol to the acceptor 
vesicle membranes. 22-NBD-cholesterol was excited at the wavelength of 469 
nm. The decay in fluorescence emission was recorded at 535 nm while a gain 
in emission by N-Rhod-PE was recorded at 581 nm. The phenomenon was 
monitored for 360 s and the data from each assay were collected in 
triplicates. 
The fluorescence intensities at both emission wavelengths were plotted 
as functions of time to obtain rate curves. Only the data of fluorescence gain 
from N-Rhod-PE were fitted to a two-phase exponential association model in 
GraphPad Prism® (ver. 6.0; GraphPad Software, La Jolla, CA) according to 
the following equation: 
Y = ' + Span×(1 − e
/01) + Span2×(1 − e
/31)         (eq. 4) 
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where, Span = (Plateau − ') × Percent × 0.1          
and   Span2 = (Plateau − ') × (100 − Percent) × 0.1          
In the above equations, t represents time in seconds; Y denotes gain in 
fluorescence by N-Rhod-PE; Y0 denotes fluorescence intensity of N-Rhod-PE 
when time (t) is zero, in the same units as Y; Plateau is the fluorescence 
intensity of N-Rhod-PE at equilibrium, in the same units as Y; k1 and k2 are 
the rate constants of fast and slow phases, respectively, expressed in s-1; and 
Percent1 represents the percentage of signal due to the fast phase. The slow 
phase was presumably caused by the spontaneous transfer of free 22-NBD-
cholesterol to acceptor liposomes. Therefore, the rate constant of the fast 
phase (k1), that corresponded to the ligand transfer rate by OSBP, was 
considered for analysis. 
The statistical significance of difference in the transfer rates (k1), in 
the presence and absence of PI(4)P in the acceptor membrane, was evaluated 
for each protein type, by performing an unpaired parametric Student’s t-test. 
The same analysis was performed to test the significance of difference in the 
Plateau, in other words the maximum amount of sterol transferred to the 
acceptor vesicle, between wtOSBP and OSBP-HH/AA. The results of these 
comparisons were plotted as bar graphs. 
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Chapter 3 
RESULTS 
This chapter details the observed trends and outcomes of the binding and 
transfer assays performed on the DPI and spectrofluorometer. The results 
provide a better comprehension of the membrane-binding preference of OSBP, 
based on the chemical nature of the constituent sterol and PIP ligands 
residing in the bilayers. My experiments highlight the role of PHD and ORD 
in enabling the wild-type protein to associate with specific type of membranes 
and transfer its sterol cargo. These studies were validated by the use of mutant 
versions of OSBP with impaired or altered domain functionalities. The 
parameters defining the kinetics of binding and transfer behaviour of OSBP 
have been reported. Lastly, the failed attempts to validate ligand extraction by 
OSBP’s have also been documented here along with the consequences of 
process improvisations and alternate analysis.   
Chapter 3 | RESULTS 
 
Page | 64  
 
3.1. Expression and isolation of OSBP from Sf21 cells 
using Baculovirus Expression Vector System (BEVS) 
 
 
3.1.1. Sf21 growth and infection with baculovirus  
Sf21 displayed a healthy exponential growth as monolayers. Over 
several passages, the average cell density at the end of each generation was 
approximately 5 × 106 cells/mL with 90 – 95 % viability (Figure 16A). 
Normal Sf21 cells displayed a spherical and somewhat granular morphology. 
Cells in a given population were unequal in sizes and attached firmly to the 
culture flask to form adherent layers. According to the literature, the mean 
diameter of Sf9 cells, a clonal isolate of Sf21 cells, is 18.5 ± 1.5 µm (Gotoh et 
al., 2008). 
At the end of the incubation period with baculovirus expression vectors 
carrying the desired coding sequences of human wtOSBP or its mutants, 
morphological differences between healthy proliferating cells and virus-
infected cells became visually apparent. The diameter of cells increased 
considerably after infection and therefore, cell size alone could be used as a 
very good indicator of successful infection, not protein expression, as reported 
by many other groups (Sander and Harrysson, 2007; Radner et al., 2012; 
Üstün-Aytekin et al., 2014). The morphological features of healthy and 
infected cells are displayed in Figure 16B. Also, a decrease in the viability 
was observed in the infected population along with a marked decrease in the 
growth rate. For OSBP expression, MOI of 0.2 was used as a standard for 
infecting Sf21 cultures (see Section 3.1.3 for explanation). 
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Figure 16: Density and morphology of Sf21 cells in culture. (A) The total 
cellular density and % viability of Sf21 cultures maintained as adherent monolayers 
are shown. Data are mean ± S.E.M. of quadruplicate cell samples collected after 
each passage of cultures grown at different time-points. (B) Bright field images of 
Sf21 cells, grown as monolayers (upper panel) and suspension cultures (lower 
panel), are shown. The lower panel shows morphological differences between healthy 
vs. virus-infected cells. The images were captured by a digital camera attached to an 
inverted microscope using 40X objective 3 days after seeding (upper panel) and 3 
days after infection (lower panel). Scale bar = 20 µm. 
(A) 
(B) 
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3.1.2. Extraction and purification of OSBP 
Chromatographic isolation of His-tagged OSBP from baculovirus-
infected cells was semi-automated by the FPLC system. During the process, 
all the undesired intracellular proteins expressed in virus-infected Sf21 cells 
were eliminated resulting in isolation, purification and enrichment of 
recombinant OSBP. This was evident from the chromatogram obtained from 
a typical run (Figure 17).  
 
Figure 17: OSBP purification by immobilized metal affinity 
chromatography. Chromatogram generated after a round of purification of OSBP 
by semi-automated IMAC-FPLC is shown. Clarified Sf21 cell lysate was equilibrated 
overnight with cobalt-iminodiacetic acid (Co2+-IDA) resin at 4 ° C. After packing the 
resin into a column, weak column binders were washed off and 6×His-tagged OSBP 
was isolated with phosphate buffered saline (pH = 7.4) containing 20 mM and 200 
mM imidazole, respectively. Protein elution was monitored by recording absorbance 
of each eluted fraction at 280 nm.   
 
The UV absorbance of the mobile phase at 280 nm decreased from an 
initial high value of 2.4 to a baseline value of 0.4 which denoted removal of 
the majority of proteins from the cell lysate. After a quick wash of the 
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stationary phase with a low concentration of imidazole, which eliminated 
other His-containing proteins bound weakly to the column, 6×His-OSBP 
elution was observed by a “peak” in the UV signal originating from the 
competitive displacement of the protein from Co2+-IDA by high concentration 
imidazole buffer. 
 
3.1.3. Quantification and characterization of purified OSBP 
Quantification of OSBP in the IMAC fractions by the Coomassie 
reagent showed that approximately 1.0 – 1.5 mg of OSBP was isolated per 
litre of Sf21 culture. A sample of wtOSBP that yielded a concentration of 2 
µM by the Bradford method, was found to have a calculated concentration of 
1.85 µM when the sample’s A280 value was translated by the Beer’s law 
(Figure 18, A and B). The two estimates were reliably close to each other 
and a mean value was therefore considered for every experiment. The 
identity of wtOSBP in the fractions eluted from the IMAC column were 
confirmed using molecular weight analysis and immunodetection.  
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R2 = 0.9893
 
(A) (B) 
Figure is continued on the next page… 
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Figure 18: Quantification and characterization of purified OSBP. (A) An UV 
absorption spectrum of wtOSBP is shown with imidazole as a reference. (B) A BSA 
standard curve used for estimating OSBP concentration using Bradford protein 
quantification assay, is displayed here. Reported data are mean ± S.E.M. of 
quadruplicate trials for each sample. (C) Molecular weight analysis of wtOSBP 
using SDS-PAGE is shown in this image. Size-based separation of proteins from 
baculovirus-infected Sf21 cells (lanes 2 & 6), clarified Sf21 lysate (lanes 3 & 7), 
unbound fraction from IMAC column (lanes 4 & 8) and eluted protein (lanes 5 & 9) 
was performed on a 10 % polyacrylamide gel. A comparison of wtOSBP yield is also 
provided between samples obtained from cells infected at an MOI of 0.1 for 72 h 
(lanes 2 – 5) vs. those infected at an MOI of 0.2 for 48 h (lanes 6 – 9). Molecular 
weight markers were loaded in lanes 1 and 10. (D) Immunodetection of wtOSBP by 
Western blot is shown here. Lane identities of samples probed with mouse anti-
OSBP mAb (dil. 1:200) are the same as that of SDS-PAGE. Both 2D and 3D images 
of SDS-PAGE and Western blot were processed by Image Lab™ Software (ver. 5.2.1, 
Bio-Rad Laboratories Inc.).  
(C) 
(D) 
Chapter 3 | RESULTS 
 
Page | 69  
SDS-PAGE results showed a distinct band, near the 100 kDa marker, 
in the sample containing pure OSBP (Figure 18C). At the same location, 
Western blot results showed the presence of OSBP by anti-OSBP mAb 
(Figure 18D). The predicted molecular mass of the protein was ~90 kDa. 
During the viral infection period, the expression level of the recombinant 
OSBP was monitored by SDS-PAGE of crude Sf21 lysates collected at the end 
of each day of infection (Supplemental Figure 1). Viral transductions were 
initially carried out at an MOI of 0.1 and OSBP-expressing cells were 
harvested 72 h following infection. However, in order to augment protein 
yield, the MOI was changed to 0.2 and incubation period was decreased to 48 
h. This modification resulted in an increase in the protein yield from ~0.5 
mg/L to ~1.5 mg/L of culture volume, as evident from the lanes 5 vs. 9 of the 
SDS-PAGE/Western blot images (Figure 18, C and D).  
 
3.2. Assessment of DPI sensitivity and optimization of 
experimental conditions 
Before designing assays to analyze lipid-protein interactions using 
DPI, it was essential to test the sensitivity of the instrument in detecting 
changes in the collective mass of biomolecules deposited on the chip surface. 
Therefore, extruded vesicles containing either DOPC or DOPC with sterols 
(cholesterol and 25-hydroxycholesterol) and PI(4)P were prepared and 
subjected to size-determination by dynamic light scattering. According to the 
size-distribution, the majority of LUVs fell within a radius range of 60 – 100 
nm in a given population of DOPC vesicles (Figure 19A). Data obtained from 
20 acquisitions, of each type of vesicle population, indicated that the mean 
radius of the predominant LUV species was 92.8 nm for DOPC only, 88.2 nm 
for DOPC + 2 mol% PI(4)P, and 83.2 nm for DOPC + 10 mol% 25-
hydroxycholesterol (Figure 19B). These values were within the 
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recommended size range of LUVs used for assays involving membrane 
immobilization on planar surfaces (Karst et al., 2012; Ouberai et al., 2013; 
Barroso et al., 2016). 
 
 
Figure 19: Size determination of large unilamellar phospholipid vesicles. 
Percent distribution of LUVs based on their sizes (A) and mean sizes of predominant 
LUV species obtained from 20 acquisitions (B) in 0.5 mM samples of DOPC, DOPC + 
2 mol% PI(4)P and DOPC + 10 mol% 25-HC Chol that were prepared in DPI buffer 
by repeated extrusion through polycarbonate membranes (pore size = 100 nm). Data 
were obtained from a dynamic light scattering spectrophotometer. 
 
Real-time response from the DPI instrument during a typical 
membrane-binding assay has been shown in Figure 20. The output signal 
showed phase shifts in the transverse magnetic (TM) and transverse electric 
(TE) polarizations of the interfering beams of light during various stages of 
the experiment. The specific binding mass of OSBP (ng/mm2), depicted in the 
graphs presented in the subsequent sections, were obtained by resolving the 
signal obtained from the protein layer adsorbed on top the surface-
immobilized lipid bilayer. It was found that the DPI technology was capable 
of detecting changes in the deposited mass of protein in the order of 10-1 
ng/mm2. 
(A) (B) 
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Figure 21: Profiles of bilayer immobilization on DPI sensor. Real-time 
adsorption, immobilization and rupture of LUVs composed of: A) DOPC only, B) 
DOPC + 2 mol% PI(4)P, C) DOPC + 5 mol% cholesterol, and D) DOPC + 5 mol% 25-
hydroxycholesterol, followed by formation of stable bilayers on the DPI sensor have 
been depicted here. The concentration of phospholipid vesicles used for each trial is 
indicated in the legend. Reported data are mean thickness obtained from duplicate 
injections of each vesicle type. 
 
Once the size of vesicles was established, the next step was to find the 
optimal concentration of LUVs that would form stable bilayers. LUVs made 
of DOPC only, DOPC + 2 mol% PI(4)P, DOPC + 5 mol% cholesterol, and 
DOPC + 5 mol% 25-hydroxycholesterol were injected over the DPI sensor at 
varying concentrations (0.08, 0.16, 0.32, 0.64, 1.27 and 2.54 mM). Adsorption 
profiles indicated that each type of vesicle was capable of forming SLBs of 4 – 
[Lipid]:  ▬ 2.54 mM ▬ 1.27 mM ▬ 0.64 mM ▬ 0.32 mM ▬ 0.16 mM ▬ 0.08 mM 
(C) (D) 
(A) (B) 
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5 nm thickness when injected at a concentration of 0.32 mM or higher 
(Figure 21, A – D).  These measurements were in agreement with the 
thickness of SLBs reported by Reimhult and co-workers (Baumann et al., 
2011). At lower concentrations (0.16 nM and 0.08 nM), vesicles containing 
only DOPC were unable to form coherent bilayers in spite of prolonged 
duration (10 min) of flow of vesicles. This was evident by the thickness of < 3 
nm, measured as an average across the whole chip surface, which indicated 
incomplete surface coverage and possible presence of bilayer islands and bare 
spots on the biosensor. Also, the rate of formation of SLBs increased with the 
lipid concentration of injected vesicles in a dose-dependent manner. From the 
observed trend, 0.5 mM was chosen for the subsequent lipid-protein 
interaction assays. 
 
3.3. Lipid recognition and membrane binding by OSBP 
 
3.3.1. OSBP bound transiently to neutral DOPC bilayers  
Since DOPC constituted the bulk of LUVs used for DPI experiments, it 
was important to study the interactions of OSBP with neutral bilayers, 
devoid of any sterol or PIP ligand, to establish a baseline binding response. 
Therefore, 1 µM protein was injected over a bilayer, made of DOPC only, at a 
rate of 25 µL/min while the interaction was recorded for 10 min and resolved 
as explained earlier (see Methods, Section 2.8). The profile of protein 
association, as a function of time, indicated substantially lower mass of 
protein deposited per unit area of surface-adsorbed bilayer in the case of 
wtOSBP as compared to OSBP-HH/AA (Figure 22). The maximum bound 
masses of the wild-type and the HH/AA mutant of the protein were ~0.5 
ng/mm2 and ~0.9 ng/mm2 of DOPC bilayer surface, respectively. 
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After the commencement of protein injection, wtOSBP formed a 
temporary layer over the membrane surface that dissociated rapidly as soon 
as the injection ended, as indicated by the sudden drop in its specific mass to 
the baseline (Figure 22). In contrast, OSBP-HH/AA remained bound to the 
bilayer surface throughout the duration of flow and exhibited much slower 
dissociation after the cessation of flow. This showed that the wild-type 
protein has much lower affinity for neutral phospholipids, such as PC, and 
therefore, exhibits poorer membrane binding than its mutant counterpart.  
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Figure 22: Interaction of OSBP with immobilized DOPC bilayer on DPI 
sensor. A typical real-time mass association curve is shown that depicts the binding 
behaviour of wtOSBP and OSBP-HH/AA with bilayers composed only of DOPC. The 
termination of sample injection is indicated by the arrow. Reported data are 
representatives of duplicate trials of each sample. 
 
Owing to the sensitive nature of the instrument in recording the 
slightest changes on the surface, minor day-to-day variation in the purity of 
protein sample as well as the surface properties of the sensor chip 
contributed to appreciable variance in the adsorbed mass data. However, 
every attempt was made to replicate as many trials as possible to quantify 
the variance.  
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3.3.2. Binding affinity of OSBP was higher for cholesterol-containing 
membranes in comparison to membranes containing oxysterol. 
When sterols were incorporated in the membrane, the overall shape of 
the association curves for wtOSBP remained essentially similar to that of the 
neutral DOPC bilayers.  
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Figure 23: Ligand-concentration dependent binding profiles of wtOSBP 
with immobilized DOPC bilayers containing sterols. Real-time associations of 
wtOSBP with DOPC bilayer containing varying mol% of 25-hydroxycholesterol (A) 
and cholesterol (B) are shown here. Reported data are means of triplicate trials of 
each sample. 
(A) 
(B) 
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The maximum bound masses of the protein remained indistinguishable 
for DOPC bilayers containing 25-hydroxycholesterol when compared with the 
ones devoid of any recognizable ligand (Figure 23A). Interestingly, the 
response was markedly different for cholesterol-containing membranes. 
Approximately two-fold higher masses of wtOSBP bound to membranes 
containing cholesterol rather than the protein’s known higher-affinity ligand, 
25-hydroxycholesterol (Figures 23B). As evident from the figure, the specific 
masses of adhering wtOSBP did not show any significant change when the 
content of either cholesterol or 25-hydroxycholesterol in the membrane was 
varied over the following range: 0, 2, 5, 10 and 20 mol%. 
 
3.3.3. Compared to sterols, OSBP showed slower dissociation from 
PI(4)P-containing membranes. 
 The binding of wtOSBP to PI(4)P-containing membranes had dramatic 
consequences. At the onset of injection, the wild-type protein adsorbed 
quickly to the bilayer followed by a gradual slow desorption over the course of 
sample flow. Moreover, with increasing mol% of PI(4)P in the membranes, 
the shape of the curves reflected distinct association. WtOSBP took longer 
time to saturate the bilayers with each increment in PI(4)P concentration 
(Range: 0, 2, 4, 6 and 8 mol%), as indicated by the dotted lines in Figure 24. 
The behaviour of wtOSBP binding to PI(4)P-containing bilayers was 
markedly different from those containing sterols for various aspects of the 
binding profiles. For example, the characteristic shape of protein-PI(4)P 
association curves was distinctly different from the relatively “flat” protein-
sterol association curves. When compared to sterol-containing bilayers, the 
dissociation of wtOSBP from PI(4)P-containing membranes was much slower 
at higher PI(4)P concentration, such as 6 and 8 mol%. This was indicated by 
a DPI signal that almost never came back to baseline at the termination of 
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protein injection, thereby indicating incomplete desorption of the interacting 
protein layer (Figure 24). 
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Figure 24: Ligand-concentration dependent binding profiles of wtOSBP 
with immobilized DOPC bilayers containing PI(4)P. Real-time associations of 
wtOSBP to DOPC bilayer containing varying mol% of PI(4)P are shown here. The 
dotted vertical lines denote the time-points when maximum mass of wtOSBP 
adsorbed on bilayers with corresponding mol% of PI(4)P. Reported data are means of 
triplicate trials of each sample. 
 
Unlike either cholesterol or 25-hydroxycholesterol, the maximum 
bound mass of protein increased with increasing mol% of PI(4)P in the 
bilayer. In spite of being consistent at lower ligand concentrations, membrane 
binding of wtOSBP, when PI(4)P was present, deviated significantly from 
that where sterols were present at higher mol% (Figure 24). At the highest 
tested concentration of ligand, i.e. 8 mol% of PI(4)P and 20 mol% of either 
sterol, the maximum specific mass of wtOSBP for bilayers with PI(4)P was 
approximately three-fold and six-fold higher than those with cholesterol and 
25-hydroxycholesterol, respectively. The specific mass-to-ligand concentration 
curve for PI(4)P roughly followed a sigmoid-pattern showing membrane 
saturation with protein at 6 mol% of PI(4)P. In the case of sterols, however, 
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the graphs did not show a tendency towards increasing protein adsorption 
with increasing amount of sterol in the membrane (Figure 25). 
 
Figure 25: Ligand-wise comparison of the membrane-binding behaviour of 
wtOSBP. Maximum specific masses of 1 µM wtOSBP bound to surface-adsorbed 
DOPC bilayers are shown as a function of varying mol% of ligands, namely, PI(4)P, 
cholesterol and 25-hydroxycholesterol. Reported data are means ± S.E.M. of 
triplicate trials.  
 
3.3.4. OSBP associated in a dose-dependent manner with membranes 
containing PI(4)P, not sterols. 
When binding assays were performed by maintaining a constant 
amount of ligand in the adsorbed membrane and varying the concentrations 
of interacting protein, wtOSBP associated in a dose-dependent manner only 
with bilayers containing PI(4)P, not sterols (Figure 26, A – C). The amounts 
of ligand, in vesicles, chosen for this test were 5 mol% of either sterol and 2 
mol% of PI(4)P. While the shape of the binding curve of each dosage of 
wtOSBP remained more-or-less “flat” for both sterols, protein association 
with PI(4)P-containing membranes followed the characteristic pattern 
observed earlier (Section 3.3.3).  
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Figure is continued on the next page… 
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Figure 26: Dose-response of wtOSBP to immobilized DOPC bilayers. Real-
time associations of varying concentrations of wtOSBP to DOPC bilayers containing 
(A) 5 mol% cholesterol, (B) 5 mol% 25-hydroxycholesterol, and (C) 2 mol% PI(4)P. 
The dotted vertical lines in curve C denote the time-points when the maximum mass 
of protein, at each corresponding dosage, adsorbed to the bilayer. Also shown is a 
plot of maximum specific masses of the protein (D) bound to bilayers containing 2 
mol% of PI(4)P (red) and 5 mol% of either sterol (blue) are shown as a function of 
protein concentration. Reported data are means ± S.E.M of duplicate trials. 
 
At the highest tested dose of wtOSBP (i.e. 2 µM), 1.0 ng of protein 
bound per mm2 surface of adsorbed membranes containing PI(4)P while only 
0.5 – 0.6 ng of protein bound to membranes containing sterols, resulting in 
the saturation of bilayer surface by protein. This is apparent from the 
binding saturation curve (Figure 26D). It is interesting to note that the rate 
of the initial rapid buildup of wtOSBP on the PI(4)P-harbouring bilayer 
increased with increasing concentration of injected protein sample. In 
addition to this, the time taken to reach the maximum bound mass was also 
observed to vary inversely with protein dosage, as indicated by the dotted 
lines in Figure 26C.  
(D) 
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3.3.5. Immunodetection-based confirmation of PI(4)P-extraction from 
adsorbed membrane by wtOSBP remained inconclusive. 
The association (and dissociation) profiles of OSBP with PI(4)P-bearing 
membranes hinted towards the possibility of ligand extraction from the 
bilayers by the wild-type protein (see Discussion and Outlook, for 
explanation). In order to test this hypothesis, immunodetection of PI(4)P 
extracted by wtOSBP was carried out by performing a fat-blot assay. The 
injected wtOSBP, that had flowed over and interacted with PI(4)P-bearing 
DOPC bilayers, was collected from the DPI effluent and was tested for the 
presence of PI(4)P using anti-PI(4)P mAb. However, the results proved 
inconclusive due to technical limitations. At first, the intensity of the blot 
signals looked directly proportional to the mol% of PI(4)P (Figure 27A, 
+wtOSBP), which explained why the protein remained bound for a longer 
duration with each increment in the ligand concentration in the bilayer. 
Interestingly, the developed colour was less intense for 6 mol% PI(4)P which 
was also in agreement with the shape of the corresponding association curve 
(Figure 24). In this specific instance, the protein remained bound to the 
membrane for a much longer duration after the termination of the injection 
as the DPI signal never returned to the baseline.  
However, these results became perplexing when a similar trend was 
also observed for a control experiment that used only DPI running buffer 
instead of wtOSBP (Figure 27A, -wtOSBP). In fact, the control blots showed 
more intense signals which indicated that more PI(4)P was extracted by the 
buffer than the actual protein. This was extremely unlikely to happen. 
Moreover, when compared to the signals from PI(4)P standards (Figure 
27B), the blots in Figure 27A showed much higher intensity while the 
maximum amount of PI(4)P available for extraction from the adsorbed 
bilayers with 6 mol% of PI(4)P was only about 4 pmol. Due to these 
discrepancies, the results were deemed inaccurate and have been ignored.  
Chapter 3 | RESULTS 
 
Page | 82  
 
 
 
Figure 27: Immunodetection of PI(4)P. A) Fat blots probed with anti-PI(4)P 
mAb are shown for detection of PI(4)P in the DPI effluent collected after injecting 1 
µM wtOSBP over bilayers containing varying amounts of PI(4)P. B) Fat blots depict 
absence of signal for wtOSBP injected over neutral DOPC bilayers and increased 
signal intensity for 2 µM protein, compared to 1 µM, when injected over DOPC + 2 
mol% PI(4)P. Signals for PI(4)P standards (with indicated amounts blotted on the 
membrane) are also displayed here. C) Shown here is a failed attempt to detect 
PI(4)P extraction by wtOSBP by means of loss-of-PI(4)P signal from surface 
adsorbed bilayers after binding and dissociation of wtOSBP. The extractable PI(4)P 
amounts were found to be below the detection limit of this assay. 
 
A second attempt was made to bypass the problems faced previously 
and obtain discernable results from the fat blot assay. This time, the aim was 
to detect the depletion of PI(4)P from the surface-adsorbed membrane after 
the completion of a wtOSBP injection, by dissolving the bilayer, probing the 
blots using anti-PI(4)P mAb and recording the loss-of-signal compared to 
buffer-injected controls. However, progress was hindered due to lack of signal 
at any mol% of PI(4)P for buffer-injected controls (Figure 27C). A quick look 
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at the PI(4)P standards  made it clear that the assay was simply not sensitive 
enough to detect amounts of PI(4)P less than 10 pmol.  Therefore, this 
approach was discarded altogether and the OSBP-HH/AA mutant was used 
to confirm the PI(4)P-extraction phenomenon. 
 
3.3.6. OSBP extracted PI(4)P from surface-adsorbed bilayers after 
recognizing the ligand by its PHD. 
Membrane binding assays were performed using the OSBP-RR/EE 
mutant, incapable of recognizing PIPs, at a single concentration of protein 
and ligand. The DPI response from an injection of 2 µM OSBP-RR/EE mutant 
over an adsorbed bilipid membrane with 2 mol% PI(4)P showed a complete 
absence of the characteristic initial buildup of mass and subsequent 
dissociation as seen in the case of wtOSBP (Figure 28A). The mutant 
associated with the bilayer in a fashion akin to the wild-type protein on 
neutral DOPC bilayer. This unequivocally showed that PHD is essential for 
recognition of PIP and docking of OSBP to the membrane for ligand 
extraction. 
 
Figure is continued on the next page… 
(A) 
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Figure 28: Association of OSBP mutants with bilayers containing PI(4)P. (A) 
DPI responses, depicting the real-time interaction of wtOSBP vs OSBP-RR/EE 
mutant with bilayers containing 2 mol% PI(4)P. (B) Association curves of OSBP-
HH/AA with bilayers containing varying mol% of PI(4)P. (C) Maximum specific 
masses of the bound HH/AA mutant (vs. wtOSBP) as a function of PI(4)P density in 
the bilayers. Reported data are means ± S.E.M. of triplicate trials. 
 
A second mutant, called OSBP-HH/AA, was tested to provide evidence 
in favor of PI(4)P-extraction from membrane by wtOSBP. OSBP-HH/AA was 
capable of recognizing PI(4)P in the adsorbed bilayers and therefore bound at 
high specific masses (Figure 28B). Judging by the essentially “flat” shape of 
(B) 
(C) 
OSBP-HH/AA 
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the curves coupled with very slow dissociation of protein from the membrane 
after the end of its flow, it could be said that this mutant was incapable of 
extracting PI(4)P from the membrane, as mentioned earlier by Ridgway and 
co-workers (Goto et al., 2016). The bound mass of OSBP-HH/AA increased 
with increasing mol% of PI(4)P ultimately reaching saturation at PI(4)P 
amounts in the bilayer beyond 2 mol% (Figure 28C). Unlike the wild-type 
protein, the time to reach maximum bound mass remained unchanged for 
trials with various concentrations of membrane PI(4)P and so were the 
association and dissociation rates. 
 
3.4. Kinetics of sterol transfer by OSBP 
 
3.4.1. 22-NBD-cholesterol showed similar binding affinity for wtOSBP 
and BSA. 
A fluorescent cholesterol analog, 22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)amino)-23,24-bisnor-5-cholen-3ß-ol or 22-NBD-cholesterol, was used  to 
study the binding of monomeric sterol with wtOSBP and OSBP-HH/AA. A 
study of the absorption behaviour of this fluorescent ligand at various solvent 
dilutions showed that it absorbed most light in the visible region of the 
electromagnetic spectrum with a maximum at the wavelength (λmax) of 469 
nm. Maximum emission was recorded at the wavelength (λem) of 535 nm. 
The initial binding response of 22-NDB-cholesterol obtained by 
monitoring the emitted fluorescence intensity showed similar affinity of the 
ligand for both the wild-type and mutant forms of OSBP. At lower 
concentrations, the ligand bound incrementally to either protein in aqueous 
solution as seen in Figure 29, before saturating the binding sites on the 
proteins at concentrations above 150 nM. Although the observed maximal 
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binding, Bmax, could not be quantified and compared between the proteins, 
normalizing the recorded fluorescence intensities helped in computing the 
dissociation constants. The estimated Kd values for 22-NBD-cholesterol to 
wtOSBP and OSBP-HH/AA were 37.3 ± 5.1 nM and 34.0 ± 2.6 nM, 
respectively. Although these were not so different from each other, a control 
experiment with bovine serum albumin (BSA) produced a Kd value of 20.0 ± 
6.0 nM, which was surprisingly at the same ballpark as the values obtained 
for OSBP. This result hinted towards non-specific binding of 22-NBD-
cholesterol with the wild-type and mutant forms of OSBP. 
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Figure 29: Saturation binding curves for fluorophore-labeled cholesterol. 
Total binding of monomeric 22-NBD-cholesterol to OSBP (wild-type and HH/AA 
mutant) and BSA (control) is shown here. The fluorescent ligand was added 
incrementally to 200 nM of specified protein every 10 min at room temperature. 
Fluorescence intensity recorded at each concentration of ligand is plotted on a linear 
scale and fitted to a one-site binding equation using a non-linear regression method. 
Reported data are as means ± S.E.M. of triplicate trials.  
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3.4.2. Natural sterols competed with 22-NBD-cholesterol for binding 
OSBP, but not BSA. 
Specificity of 22-NBD-cholesterol for OSBP was examined by allowing 
natural sterols, such as cholesterol or 25-hydroxycholesterol, to compete with 
protein saturated with the fluorescent sterol analog. A steady decay in NBD 
florescence due to incremental addition of either natural sterol showed 
competitive displacement of the ligand from the sterol-binding pocket of 
OSBP (Figure 30, A and B). 25HC proved to be the most potent competitor 
requiring lower concentrations to reach the minimum fluorescence. This was 
evident by complete displacement of 22-NBD-cholester at 100 nM for both 
wtOSBP and OSBP-HH/AA. For cholesterol, a higher concentration was 
required to outcompete the fluorescent sterol, since the decay in fluorescence 
became exceedingly slow only after 150 – 200 nM of added cholesterol. 
Interestingly, no competition was observed in case of BSA (Figure 30C), 
which was an indication that 22-NBD-cholesterol bound BSA in a non-specific 
manner that was due to the absence of a conserved sterol-binding pocket. The 
competitive binding curves for wtOSBP and OSBP-HH/AA with log-
transformed ligand concentration (Figure 30, D and E) enabled estimation 
of EC50 values of cholesterol and 25-hydroxycholesterol for both proteins. 
These values are summarized in Table 1.  
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Figure is continued on the next page… 
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Figure 30: Competition binding curves for fluorophore-labeled cholesterol. 
Competitive displacement of 22-NBD-cholesterol from ligand-saturated (A) wtOSBP 
(B) OSBP-HH/AA, and (C) BSA by cholesterol and 25-hydroxycholesterol is shown. 
500 nM of the fluorescent ligand was incubated with 200 nM of protein followed by 
incremental addition of natural sterols every 10 min at room temperature. 
Competition binding curves are plotted on a linear scale. Data from (A), (B) and (C) 
were normalized, re-plotted against log concentration (X-axis) and fit to one-site 
competition equation using a non-linear regression method. Behaviour of both 
sterols on wtOSBP vs. BSA (D) have been compared with that of OSBP-HH/AA vs. 
BSA (E). The estimated EC50 values of wtOSBP are reported in Table 1. Reported 
data are means ± S.E.M. of triplicate trials.  
 
It should be noted that although the starting fluorescence of 22-NBD-
cholesterol-bound OSBP (both wild-type and mutant) was recorded prior to 
the addition of either unlabeled sterol during the competition assays, the 
data point could not be plotted on the normalized data (Figure 30, D and E) 
(E) (D) 
(C) 
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due to log transformation of the concentration of unlabeled sterol on the X-
axis. The sigmoid-shape of the competitive binding of natural sterols to OSBP 
could not be appreciated due to lack of initial additions of minuscule 
concentrations of natural sterols in sub-nanomolar range. Nevertheless, the 
one-site competitive-binding model was able to predict the starting 
fluorescence and estimate the EC50 values, tabulated in Table 1. 
 
Table 1: EC50 values from competition assay. Half-maximal effective 
concentrations (EC50) of natural sterols for competitive binding to OSBP against 22-
NBD-cholesterol. 
 
   OSBP 
variant 
EC50 (nM) 
Cholesterol 25-Hydroxycholesterol 
Wild-type 15.6 ± 0.7 5.0 ± 0.5 
HH/AA mutant 13.8 ± 0.7 12.7 ± 0.7 
 
3.4.3. Presence of PI(4)P in acceptor vesicles did not alter the sterol-
delivery rate of OSBP in FRET-based transfer assay 
A fluorescent phospholipid analog, N-(lissamine rhodamine B 
sulfonyl)-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, commonly known as 
N-Rhod-PE, was used as a FRET partner of 22-NBD-cholesterol to study the 
transport of sterol to small unilamellar vesicles by wtOSBP and OSBP-
HH/AA. This fluorescent probe showed light absorbance in the visible region 
of the electromagnetic spectrum with a λmax of 560 nm. For the experiment, 
small vesicles containing either DOPC and 3 mol% N-Rhod-PE or DOPC, 3 
mol% N-Rhod-PE and 4 mol% PI(4)P were prepared and subjected to size-
determination by dynamic light scattering. In a given population of these 
SUVs, the radius of the majority of the vesicles was found to be within 30 – 
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60 nm (Figure 31A). Data obtained from 20 acquisitions, indicated that the 
mean radius of the predominant SUV species was 57.5 nm for both types of 
DOPC vesicles, with or without PI(4)P (Figure 31B). 
 
 
Figure 31: Size determination of small unilamellar phospholipid vesicles. 
(A) Percent distribution of SUVs based on their sizes and (B) mean sizes of 
predominant SUV species obtained from 20 acquisitions in 0.2 mM samples of DOPC 
+ 3 mol% N-Rhod-PE and DOPC + 3 mol% N-Rhod-PE + 10 mol% PI(4)P prepared in 
DPI buffer by sonication and repeated extrusion through polycarbonate membranes 
(pore size = 50 nm). Data were obtained from a dynamic light scattering 
spectrophotometer. 
 
Due to FRET, the NBD fluorescence was expected to be quenched over 
time with a concomitant increase in Rhodamine fluorescence, depending upon 
the rate of delivery of 22-NBD-cholesterol to acceptor vesicles by OSBP. It 
was evident from the rate curves (Figure 32, B and D) that the decrease in 
NBD fluorescence was substantially lower in magnitude when compared to 
the gain in Rhodamine fluorescence. The kinetic model representing two-
phase exponential association was fitted to Rhodamine data to estimate the 
transfer rates. Only the rates of initial “fast” phases were considered in the 
analysis because they truly represented protein-mediated sterol transfer. The 
“slow” phases were caused by the spontaneous transfer of free fluorescent 
sterols to the acceptor membranes. For wtOSBP, a gradual increase in 
(A) (B) 
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transfer was observed which did not reach equilibrium during the period 
when Rhodamine fluorescence was monitored (Figure 32B). This was true 
for acceptor vesicles with or without PI(4)P. The differences in the estimated 
maximum fluorescence intensity at equilibrium for these vesicles were found 
to be statistically non-significant (Figure 32E, wtOSBP). The same 
observation was made for the rate constants, which did not change between 
the two types of vesicles (Figure 32C, wtOSBP). 
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Figure 32: Transfer of 22-NBD-cholesterol to small unilamellar vesicles by 
OSBP. (A) A general scheme to monitor sterol transfer by OSBP to acceptor 
vesicles, using FRET, is depicted. Also shown are rate curves depicting change in 
Rhodamine fluorescence as an indicator of sterol transfer by (B) wtOSBP and (D) 
OSBP-HH/AA. The insets depict change in NBD fluorescence for the corresponding 
assays. Rhodamine data were fitted to two-phase exponential association model 
using a non-linear regression method. The estimated rate constants of fast phases 
(C) and maximum intensity of Rhodamine fluorescence at equilibrium (E) were 
compared between wtOSBP and OSBP-HH/AA and displayed as bar graphs (F.I. = 
fluorescence intensity). Data are means ± S.E.M. of triplicate trials. Statistical 
significance of difference in these kinetic parameters between the two proteins and 
the two types of acceptor vesicles are indicated above each set of bars (unpaired 
Student t-test, * denotes p < 0.05, ns = non-significant).     
 
For OSBP-HH/AA, the transfer rates were similar in magnitude when 
compared to wtOSBP and the rate constants for acceptor vesicles devoid of 
PI(4)P were not significantly different from the ones for vesicles containing 
PI(4)P (Figure 32C, OSBP-HH/AA). The rate curves indicated that the 
mutant, like the wild-type protein, did not reach an equilibrium within the 
observed duration of the assay (Figure 32D). Although the estimated 
maximum fluorescence intensity at equilibrium didn’t differ with the amount 
of PI(4)P in the acceptor vesicle, they were found to be significantly smaller 
than the values obtained from sterol transfer by wtOSBP indicating higher 
net delivery of sterols by the wild-type protein than the mutant (Figure 
32E).  
OSBP-HH/AA 
(E) (D) 
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Chapter 4 
DISCUSSION AND OUTLOOK 
This section dissects the membrane binding behaviour of OSBP and its 
mutants based on the findings from the assays demonstrated on the DPI. 
Special emphasis has been given to the interaction of OSBP with membranes 
containing PI(4)P and the ability of this ligand to modulate the protein’s 
affinity for the membrane. The reasoning behind the kinetic rates, witnessed 
during the transfer of fluorescent sterol analogs to acceptor vesicles by OSBP, 
has been provided here. Also included is the description of the probable causes 
of experimental failures and justification of modified approaches along with 
suggestions of investigative designs for future. Taken together, this chapter 
illustrates my attempt to link the results with the characteristics already 
attributed to OSBP in the literature while highlighting some newfound trends. 
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4.1. Estimation of the maximum theoretical specific mass 
of membrane-bound OSBP 
The DPI was operated under flow conditions and the adsorbed protein 
layers were arguably in a pseudo-equilibrium state. In other words, OSBP 
was associating with and dissociating from the immobilized phospholipid 
bilayer throughout the duration of its flow over the sensor chip. It was crucial 
to have a clear knowledge of how much surface of the bilayer could actually 
be occupied by OSBP, before drawing any meaningful conclusion from the 
binding isotherms obtained from the instrument. Therefore, a theoretical 
estimation of the expected DPI response due to complete coverage of the 
adsorbed membrane by the protein was pertinent. 
In order to achieve that, the diameter of the sterol binding face of the 
OSBP-related domain (ORD) was calculated from the crystal structure of 
Osh4 (PDB ID: 1ZHX). It was found to be ~60 Å (Schulz et al., 2009), thus 
yielding an approximate circular surface area of 2830 Å2. Therefore, the 
sterol-binding ORD of each OSBP molecule would interact with the adsorbed 
bilayer over an area of 2830 Å2. One square millimeter of membrane surface 
was found to be occupied by approximately 3.54 × 1010 OSBP molecules 
(58.72 fmol) of OSBP, which was equivalent to 5.28 ng of OSBP/mm2 (M.W. of 
OSBP = 90,000 g.mol-1). If one had to assume that a DOPC bilayer covered 
the entire surface of the sensor chip, then based on the calculations outlined 
above, a specific protein mass of 5.28 ng/mm2 would indicate 100 % surface 
occupancy by OSBP. For membranes containing PI(4)P, the number of PI(4)P 
molecules per unit surface area was calculated by dividing 1 mm2 by 72.4 Å2 
(the approximate area of a phosphatidylcholine headgroup) (Lewis and 
Engelman, 1983; Kučerka et al., 2005) and multiplying the calculated value 
by the mol% of PI(4)P in the bilayers. If OSBP interacted with PI(4)P in 1:1 
stoichiometry, then the maximum mass of protein that associates with the 
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membrane would be equivalent to the number of PI(4)P molecules on the 
upper leaflet of the adsorbed bilayer, until that number exceeds 3.54 × 1010. 
The calculated maximum specific masses are shown in Table 2. The 
deviation of the observed specific masses from the ones calculated here are 
highlighted in Section 4.5.  
 
Table 2: Theoretical estimation of maximum mass of adsorbed protein on 
immobilized bilayers. Maximum masses of protein theoretically expected to bind 
per mm2 of immobilized bilayers containing varying mol% of PI(4)P in the DPI-based 
assays. Masses have been calculated assuming 100% chip coverage by the bilayers 
and OSBP interaction with PI(4)P at 1:1 stoichiometry.  
 
Amount of 
PI(4)P in 
bilayer 
Number of PI(4)P 
molecules/mm2 
Number of OSBP 
molecules/mm2 
Max. specific 
mass 
(ng/mm2) 
1 mol% 1.38  1010 1.38 × 1010 2.06 
2 mol% 2.76 × 1010 2.76 × 1010 4.13 
4 mol% 5.52 × 1010 * 3.54 × 1010 * 5.28 
6 mol% 8.29 × 1010 * 3.54 × 1010 * 5.28 
8 mol% 1.10 × 1011 * 3.54 × 1010 * 5.28 
 
* Under these circumstances, more PI(4)P molecules were available than the 
maximum number of OSBP molecules that could occupy the surface. Thus, the 
concentration of injected protein became the limiting factor for binding. 
 
Similar estimations were not performed for bilayers containing sterols 
because the characteristic association followed by dissociation, as observed 
during the exposure of wtOSBP to PI(4)P-containing membranes, was absent 
for bilayers with sterols. Therefore, the specificity of protein-membrane 
interaction in those cases remains inconclusive and requires further 
investigation. 
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4.2. Behaviour of OSBP towards neutral PC bilayers 
When compared to α-tocopherol transfer protein (TTP), another LTP 
studied earlier in our lab (Baptist et al., 2015), the interaction of wtOSBP 
with DOPC-only bilayers was not drastically different. TTP binds well to 
DOPC forming an adsorbed protein mass of ~0.75 ng/mm2 when 1.0 µM of 
protein is exposed to an immobilized bilayer. In contrast, wtOSBP showed 
poorer binding, with an adsorbed mass of 0.5 ± 0.4 ng/mm2. However, unlike 
wtOSBP, which was injected over a pure DOPC membrane, the TTP binding 
assay was performed on a bilayer made of 9:1 DOPC:DOPS. It should be 
noted that the “background” of a non-specific signal, caused by a change in 
the refractive index of the bulk medium, for any protein injected across the 
chip was ~0.2 ng/mm2. It can be argued that in the absence of a charged 
headgroup, OSBP is not likely to associate with any phospholipid membrane, 
which agrees with the results obtained here. The reason behind this is that 
the protein does not have any specialized domain for recognizing or binding 
PC. Therefore, any change in the refractive index caused by wtOSBP was due 
to non-specific interactions of its solvent-exposed amino acids with DOPC 
headgroup, possibly explaining why the protein layer was unstable and 
dissociated immediately after the cessation of protein flow (see Results, 
Section 3.3.1, Figure 22). This was, however, not the case with OSBP-
HH/AA, which formed a layer with about two-fold higher mass than wtOSBP, 
and dissociated at a much slower rate when the protein injection ended. 
The His-524 and His-525 pair stabilizes the headgroup of PI(4)P at the 
entrance to the hydrophobic tunnel of ORD (Figure 4C and 4D) while the 
acyl chains remain inserted inside the pocket via non-specific interactions 
(Tong et al., 2016). His → Ala mutation in the ORD of OSBP-HH/AA renders 
the protein non-functional in terms of its ability to extract PI(4)P from 
membranes (Goto et al., 2016). Im and co-workers have elaborated that in the 
absence of ligand, potential phospholipid binding sites of Osh4 are exposed 
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and the protein is positioned for membrane docking (Im et al., 2005). In light 
of this knowledge, it can be said that the higher preference of OSBP-HH/AA 
for DOPC membranes than the wild-type protein was probably an outcome of 
the reduced polarity (increased hydrophobicity) of the mutant at the PI(4)P-
accommodating site in the ORD. However, a lid-truncated structure of Osh4 
(PDB ID: 1ZI7) shows that the two His residues are located far from the 
membrane-interacting surface of the protein (Figure 33). This weakens the 
above argument. Therefore, the precise reason for the lower adsorbed mass of 
wtOSBP to DOPC bilayers, compared to OSBP-HH/AA, remains unclear and 
warrants further investigation. It is possible that the mutant protein orients 
differently around the surface of bilayer which can alter its affinity for the 
membrane. 
 
Figure 33: Position of the conserved His pair of Osh4 with respect to the 
surface of the bound membrane. X-ray crystallographic structure of Osh4/Kes1 
with truncated N-terminal lid is shown here. The His-143 and His-144 pair 
(magenta) is crucial for stabilizing the headgroup of PI(4)P in the ORD. The β-barrel 
(a.a. 117 – 307), forming the hydrophobic pocket for harbouring ligand, is coloured 
yellow. The surface of the phospholipid membrane in contact with protein is coloured 
blue. The image is prepared in PyMOL (ver. 1.7.4.5) from the PDB structure 1ZI7 
solved by X-ray diffraction at 2.5 Å resolution (Im et al., 2005). 
His-143 
iHis-144 
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4.3. Binding of OSBP to sterol-containing membranes 
Binding of wtOSBP to sterol-containing bilayers showed some 
interesting trends. It is well known that 25-hydroxycholesterol displays 
higher affinity for wtOSBP than cholesterol, as evident from the Kd of 10 nM 
of the former when compared to 170 nM of the latter (Dawson et al., 1989a; 
Ridgway et al., 1992; Wang et al., 2002, 2008). This attribute of the protein, 
however, was not reflected from its membrane binding behavior in this study. 
In other words, the DPI association curves, obtained from the experiments 
described in this thesis, showed nearly two-fold higher specific bound mass of 
protein over cholesterol-containing membranes than the ones with the same 
density of 25-hydroxycholesterol (see Results, Section 3.3.2, Figure 23) 
even though 25HC is a known high-affinity ligand of ORPs (Dawson et al., 
1989a, 1989b).  
Also noteworthy was the protein’s lack of preference for binding 
bilayers with 25HC, when compared to neutral DOPC bilayers. This was 
apparent from the similar magnitude of bound mass of protein to both types 
of membranes. It seems that the presence of either cholesterol or oxysterol 
changes the nature of the membrane and the protein, capable of sensing such 
a change, may very well adapt its affinity towards the membrane. However, 
the precise mechanism could not be deduced from the results in hand. Among 
the factors that regulate the protein binding, the membrane curvature could 
play a significant role. The lid region of yeast ORP Osh4 corresponds to an 
unstructured sequence, commonly known as the ALPS motif (Drin et al., 
2007). Owing to the affinity of this domain for membranes with loose lipid 
packing, Osh4 was shown to bind preferentially to anionic membranes with 
high positive curvatures (de Saint-Jean et al., 2011). That being said, a 
tighter lipid packing, and to some extent formation of ordered lipid 
microdomains, can be expected due to incorporation of either oxysterol or 
cholesterol in the bilayers (Xu and London, 2000). Immobilization and 
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rupture of vesicles on the biosensor chip, to form planar surface-adsorbed 
bilayers, causes loss of positive membrane curvature. Taken together, these 
factors could be responsible for making the movement of sterol from the 
membrane to the ORD of OSBP energetically unfavorable on the DPI 
platform.  
Both types of DPI assays, one in which the mol% of sterol was kept 
constant while the protein dosage was varied and the other in which the 
protein concentration was kept constant but the mol% of sterol in the 
membrane was varied, yielded somewhat similar responses. Although the 
shapes of the curves were distinguishable between the various protein doses, 
the maximum bound mass appeared to be fairly constant for the oxysterol. 
Cholesterol, on the other hand, produced similar-looking curves with the 
peak bound mass being constant throughout both assay types (see Results, 
Section 3.3.4, Figure 25A, -B and -D). Due to time constraints and lack of a 
steady supply of protein, the sterol-binding assays could not be performed 
with OSBP-HH/AA. In fact, the mutations in the  His-524 and His-525 pair in 
the ORD is only known to hamper the extraction and transport of PIPs, not 
sterols (Im et al., 2005; de Saint-Jean et al., 2011). Therefore, the DPI 
response for this mutant is not expected to be markedly distinguishable from 
that of the wild-type. Nevertheless, this study should provide a decent control 
for the behaviour of OSBP towards sterol-containing membranes in the 
future.  
 
4.4. High affinity of OSBP for membranes with PI(4)P 
The response of OSBP towards PIP-bearing membranes provided 
useful insights into the events occurring at the OSBP-membrane contact 
sites. I chose to work with PI(4)P, a cognate ligand for the conserved PHD, 
found in several members of the ORP-family including the archetype OSBP. 
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After the discovery of a PIP binding site in the hydrophobic pocket of the 
ORD of yeast protein Osh4 (de Saint-Jean et al., 2011), Antonny and co-
workers have elaborated that PI(4)P serves as an exchangeable ligand for 
sterol in the OSBP signaling pathway (Mesmin et al., 2013). The wild-type 
protein was able to station itself at the PI(4)P-containing bilayers on the DPI 
sensor, which was evident by a rapid increase in adsorbed protein mass 
during the early part of protein injection (see Results, Section 3.3.3, Figure 
24). The recognition of PIP and subsequent docking of wtOSBP to PI(4)P-
containing bilayers occurred by the virtue of the protein’s PHD. A double-
arginine mutant of this domain, named OSBP-RR/EE, failed to identify 
PI(4)P and exhibited protein adsorption response similar to binding DOPC 
bilayers (see Results, Section 3.3.6, Figure 28A). This observation was in 
agreement with the impaired ability of the mutant to associate with the 
membrane via PI(4)P-PHD interaction (Levine and Munro, 1998, 2002; Ngo 
and Ridgway, 2009; Goto et al., 2016).  
The protein began to desorb slowly from bilayers with PI(4)P soon after 
reaching a threshold bound mass during the course of the injection. This 
dissociation of membrane-protein complex hints strongly towards a 
possibility of protein-mediated extraction of PI(4)P molecules from the 
bilayer. The bilayer is gradually depleted of PI(4)P and the protein molecules 
arriving at the sensor during the latter part of the injection sensed a 
membrane devoid of its ligand. Consequently, wtOSBP showed little affinity 
for the PI(4)P-stripped DOPC membranes. In agreement with this 
explanation, the time taken by the protein to reach the maximum adsorbed 
mass depended reciprocally on its injected concentration when the mol% of 
PI(4)P was kept constant in the bilayer (see Results, Section 3.3.4, Figure 
26C). Beyond the protein concentration of 0.25 µM, the rates of association 
increased steadily in a dose-dependent fashion and were always higher than 
the dissociation rates. The gradual depletion of wild-type protein mass from 
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PI(4)P-containing bilayers, however, should not be compared with the rapid 
desorption of wtOSBP from neutral DOPC bilayers at the end of protein flow. 
This was arguably caused by bulk phase difference in the sample flowing over 
the chip when only a small amount of protein bound to the membrane. 
 
 
 
Figure 34: Proposed events occurring during the interaction of wtOSBP 
with DOPC bilayers containing PI(4)P. The illustration depicts various 
equilibria that exist at the protein-membrane interface during the flow of wtOSBP 
over immobilized PI(4)P-containing bilayers. The association and dissociation of 
protein observed on the DPI is a culmination of three separate events defined by six 
independent rates.  
 
My attempt to determine the rate constants ka and kd was challenged 
by the lack of any existing model that fits such protein behaviour. The closest 
resemblance was found with non-linear association then dissociation kinetics 
which assumes association of ligand with protein that reaches a plateau after 
a certain period of time, followed by dissociation that is initiated either by 
adding an antagonist or by massive dilution. This was not suited for the DPI 
curves because both adsorption and desorption were observed during the 
steady flow of protein over the membrane surface. This was further 
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complicated by the fact that the DPI only showed a global response from the 
events occurring at the protein-membrane interface which could be described 
by three distinct equilibria: i) association (ka) and dissociation (kd’) of virgin 
protein, ii) uptake (kon) and delivery (koff) of PI(4)P, and iii) dissociation (kd) 
and association (ka’) of PI(4)P-bound protein (Figure 34). Therefore, the true 
ka and kd could not be determined. 
More mass per mm2 of wtOSBP bound to bilayer surfaces with PI(4)P, 
unlike sterol-containing membranes. The time taken by wtOSBP to saturate 
the membrane increased in direct proportion to the mol% of PI(4)P. At a 
particularly high density of PI(4)P, for example 8 mol%, there was a complete 
absence of protein dissociation from the bilayer during the course of the 
injection. It may be that, past a critical concentration of PI(4)P, the dimeric 
OSBP (Dawson et al., 1989a; Lehto and Olkkonen, 2003) can bind to two 
molecules of PI(4)P simultaneously, which can possibly hinder lipid 
extraction and protein desorption from the bilayer surface. 
 
4.5. Evidence of PI(4)P-extraction from membrane by 
OSBP 
OSBP-HH/AA, unlike its wild-type counterpart, showed significantly 
higher adsorption to PI(4)P-containing bilayers compared to neutral DOPC 
bilayers. The mutant, devoid of any PIP-extracting ability, couldn’t leave the 
bilayer but remained strongly anchored via its PHD, long after the injection 
ended (see Results, Section 3.3.6, Figure 28B). Using the theoretical 
values of maximum possible mass of protein that could occupy the membrane 
surface, shown in Table 2, the actual surface coverage by OSBP was 
calculated based on the peak adsorbed masses obtained during the 
experiment. The behaviours of wtOSBP and OSBP-HH/AA were compared in 
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Table 3. The coverage, as expected, was lowest in the case of neutral DOPC 
bilayers due to the low affinity of the protein for bilayers lacking anionic 
phospholipids (de Saint-Jean et al., 2011).  
 
Table 3: Coverage of DPI sensor surface by OSBP. Reported are the percent 
coverage of a lipid bilayer by OSBP based on maximum bound mass of protein/mm2 
of the chip surface, as observed experimentally. Reported masses are means ± 
S.E.M. of triplicate trials. 
 
Bilayer Composition 
wtOSBP OSBP-HH/AA 
Specific 
Mass 
(ng/mm2) 
% 
Coverage 
Specific 
Mass 
(ng/mm2) 
% 
Coverage 
DOPC only 0.5 ± 0.4 10.0 1.7 ± 0.7 31.2 
DOPC + 1 mol% PI(4)P 0.7 ± 0.2 34.0 3.1 ± 0.3 149.1 
DOPC + 2 mol% PI(4)P 1.0 ± 0.1 24.7 5.0 ± 0.4 120.2 
DOPC + 4 mol% PI(4)P 1.6 ± 0.3 30.7 5.1 ± 0.6 96.9 
DOPC + 6 mol% PI(4)P 3.4 ± 0.7 63.4 4.5 ± 0.2 84.7 
DOPC + 8 mol% PI(4)P 3.2 60.4 5.1 ± 0.8 96.3 
 
Since purified OSBP exists as homodimer (Dawson et al., 1989b), the 
unusually high membrane surface coverage by the double-histidine mutant at 
low mol% of PI(4)P could be explained as follows: a PI(4)P-poor membrane 
will allow only one OSBP molecule of the dimer to anchor with the ligand 
while the other molecule stays ligand-free due to scarcity of PI(4)P in its 
vicinity. In such a scenario, the binding stoichiometry becomes 2:1 (protein to 
ligand) which closely agrees with the observed 150 % coverage at 1 mol% 
PI(4)P. As the membrane gets richer in PI(4)P, both members of the OSBP 
dimer attach themselves to adjacent PI(4)P molecules, now available in 
abundance in the bilayer, thereby shifting the stoichiometry to 1:1. This 
explains the observed 100 % surface coverage at higher PI(4)P density. In 
contrast, wtOSBP could never achieve a near 100 % coverage when it 
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interacted with the bilayers that contained physiologically relevant amounts 
of PI(4)P. This was caused by constant ligand extraction and departure of the 
ligand-bound protein from the bilayers. Taken together, the data from 
wtOSBP and OSBP-HH/AA demonstrated that OSBP was capable of 
recognizing the PI(4)P ligand in surface-adsorbed bilayers, associating with 
the membrane in a ligand concentration-dependent manner and extracting 
PI(4)P before departing from the membrane surface. This function was 
hampered when the ability of the protein to recognize PI(4)P was 
compromised. 
 
4.6. Factors responsible for the failure of immuno-
detection of protein-extracted PI(4)P 
My attempts to detect PI(4)P extracted by wtOSBP by 
immunodetection, remained unresolved for several reasons. The DPI effluent, 
containing the running buffer that was injected as a control over the 
adsorbed PI(4)P-containing bilayer, tested positive for PI(4)P when blotted on 
nitrocellulose membrane and probed with anti-PI(4)P antibody (see Results, 
Section 3.3.5, Figure 27). This was a technical artifact because it was 
highly unlikely for PI(4)P, which was incorporated into the adsorbed bilayer, 
to leach out into the buffer stream. Moreover, the intensity of the blot signals, 
for control and actual experiments conducted with 4 mol% PI(4)P in the 
bilayers, were unexpectedly higher than 10 nmol PI(4)P standard. This 
couldn’t have happened because the amounts of PI(4)P extractable from the 
adsorbed membranes were in the range of 1 – 6 pmol. Therefore, it was 
concluded that the signals noticed on the fat-blots were caused by the 
residual lipids, including PI(4)P, sticking to the inner walls of fluidics tubing, 
that got included in the collected effluent despite the best efforts to eliminate 
them by rigorous washes. 
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A second attempt made to confirm PI(4)P extraction, by means of 
detecting loss-of-PI(4)P signal in bilayers exposed to wtOSBP when compared 
to a buffer control, also remained inconclusive for two reasons. First, the 
amounts of PI(4)P present on the membranes were too low for this antibody-
based assay to detect. Second, the ordinary methanol-chloroform-based 
PI(4)P extraction protocol, followed for this assay, might have resulted in the 
loss of PIP by spontaneous hydrolysis. These methods, originally proposed by 
Bligh & Dyer et al. (Bligh and Dyer, 1959) and Folch et al. (Folch et al., 1957), 
have been criticized for poor recoveries of phosphoinositides and other polar 
acidic lipids (Pettitt et al., 2006). PIP extraction under mildly acidic condition 
using citric acid/sodium phosphate buffer (pH = 3.6) and butan-1-ol can 
improve recovery by minimizing phosphoinositide deacylation and possible 
phosphate loss commonly encountered during acidification by HCl (Pettitt et 
al., 2006; Zhao and Xu, 2010). 
  
4.7. Examining monomeric sterol-binding by OSBP using 
fluorescent sterol analog 
Judging by the interaction of 25-hydroxycholesterol with the ORD 
(Figure 35), 22-NBD-cholesterol seems capable of inserting its steroid ring 
into the hydrophobic tunnel of the ORD. This, however, can give rise to some 
steric hindrance between the bulky NBD group and the N-terminal lid. But 
the fact that NBD’s fluorescence is greatly reduced in polar solvents, due to 
the formation of hydrogen bonds between the solvent and fluorophore (Lin 
and Struve, 1991), makes it a great tool for investigating lipid-protein 
interactions and transport of lipid molecules between organelles (in vivo) and 
artificial model vesicles (in vitro). 22-NDB-cholesterol was, therefore, chosen 
for the assays described in this thesis. 
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Figure 35: Crystal structure of 25-hydroxycholesterol-bound Osh4. A cartoon 
representation of the yeast ORP Osh4 bound with 25HC (blue with O-atom coloured 
red) is shown. Sterol molecule binds within the hydrophobic tunnel formed by 
antiparallel β-sheets (yellow). Ligand uptake and exchange is controlled by a flexible 
N-terminal lid (dotted circle). The images are prepared in PyMOL (ver. 1.7.4.5) from 
the 1HZX structure solved by X-ray diffraction at 1.5 Å resolution (Im et al., 2005). A 
structural comparison of 25-hydroxycholesterol with 22-NBD-cholesterol, showing 
the relative position of 25-hydroxyl (red) and 22-NBD (blue) groups with respect to 
cholesterol, is also depicted here. 
90 ° 
Side-view of Osh4-ORD 
Top-view of Osh4-ORD 
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The binding of the fluorescent cholesterol with both wtOSBP and 
OSBP-HH/AA followed a distinct hyperbolic response with respect to the 
concentration of added ligand (see Results, Section 3.4.1, Figure 29). The 
Kd of 22-NBD-cholsterol for wtOSBP was 37.3 ± 5.1 nM. This can be 
compared to the saturable binding of radiolabeled [3H]25-hydroxycholesterol 
with OSBP at a Kd of 28 ± 5 nM, reported by Ridgway and co-workers (Goto et 
al., 2012) and [3H]22(R)-hydroxycholesterol with ORP2 at Kd of 14 nM, 
reported by Olkkonen and associates (Hynynen et al., 2009). A significantly 
lower affinity of Osh4 towards cholesterol, evident from a Kd of 300 nM, was 
reported by Im and colleagues (Im et al., 2005). Since Osh4 is structurally 
much simpler than OSBP, it is not surprising to believe that the additional 
domains in the latter have evolved to stabilize the overall structure of the 
cholesterol-ORD complex, enabling the protein to participate in the 
trafficking of a wider range of sterols. The affinity of 22-NBD-cholesterol for 
OSBP-HH/AA (Kd = 34.0 ± 2.6 nM) was similar to that for wtOSBP. It was in 
agreement with the fact that this mutant had intact sterol-binding ability 
and therefore, its affinity for cholesterol should not be affected due to the 
existing His → Ala mutations. 
An interesting outcome of the monomeric sterol binding assay was the 
binding of 22-NBD-cholesterol with bovine serum albumin (BSA) with an 
affinity similar to that for OSBP. Albumin is one of the most abundant 
proteins present in the blood serum. It is known to be involved in cholesterol 
metabolism by acting as a shuttle to enhance cholesterol efflux from cells and 
incorporation of cholesterol into extracellular acceptors, such as lipoproteins 
(Fielding and Moser, 1982; Zhao and Marcel, 1996; Sankaranarayanan et al., 
2013). In spite of such evidence, albumin is not known to directly associate 
with cholesterol (Haberland and Reynolds, 1973). It can, however, bind a 
multitude of steroid and other lipophilic hormones with low affinity (Kd 
values in mM – µM range) (Baker, 2002). With that in mind, it was normal to 
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expect 22-NBD-cholesterol to bind non-specifically with BSA. The non-
specific nature of such an association was verified by the competition assays 
wherein the natural sterols were unable to displace 22-NBD-cholesterol from 
the binding sites of albumin but quite effectively competed with the 
fluorescent sterol analog for the conserved ORDs of both wtOSBP and OSBP-
HH/AA (see Results, Section 3.4.2, Figure 30). The EC50 for competitive 
binding was three times higher for cholesterol than 25-hydroxycholesterol. 
This was in agreement with the higher affinity of oxysterol for OSBP than 
cholesterol documented by other groups (Dawson et al., 1989a; Ridgway et al., 
1992; Wang et al., 2002, 2008). 
 
4.8. Monitoring OSBP-mediated sterol transfer by FRET 
Transfer of the fluorescent cholesterol analog to acceptor vesicles by 
OSBP was monitored by measuring FRET between 22-NBD-cholesterol and 
N-Rhod-PE. The NBD group exhibited a low initial fluorescence and the 
decay in its signal recorded at 535 nm, caused by energy transfer to 
Rhodamine, was not appreciable as evident from the traces that remained 
essentially “flat” (see Results, Section 3.4.3, Figure 32, B and D, insets). 
Due to the bulky nature of the NBD group, the fluorescent cholesterol analog, 
22-NBD-cholesterol, may find itself in a rather solvent exposed environment 
within the ORD of OSBP than its natural counterpart (Figure 35). 
Therefore, when delivered to the acceptor membrane, the NBD fluorescence 
may increase substantially due to its transition to a more hydrophobic milieu. 
Although the emitted energy should be quenched by Rhodamine due to 
FRET, the fact that there wasn't a prominent decay could be explained by the 
prediction that the NBD traces were actually displaying a fluorescence gain 
overlapped with decay due to sub-optimal or inefficient quenching by 
Rhodamine, resulting in an overall “flat” response. In essence, the poor 
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reporting of the NBD fluorophore when trapped inside OSBP makes it a poor 
tracker of ligand transfer. Therefore, the kinetics of the transfer was defined 
by the fluorescence emission of Rhodamine at 581 nm upon excitation of NBD 
group at 469 nm. 
The results showed similar transfer rates for OSBP-HH/AA when 
compared to wtOSBP for vesicles containing DOPC, 3 mol% N-Rhod-PE and 4 
mol% PI(4)P. Also, the total amount of ligand transferred by the wild-type 
protein was significantly higher than that by the double histidine mutant. 
These outcomes can be explained by the fact that due to impaired PI(4)P 
recognition, OSBP-HH/AA could not exchange its ORD-bound sterol for 
PI(4)P at the surface of the membrane. Therefore, it could spontaneously 
deliver, albeit rapidly, a smaller amount of sterol into the acceptor vesicle. 
wtOSBP, on the other hand, delivered a substantial amount of cholesterol, 
presumably by exchanging it for PI(4)P. However, the intensity of emitted 
fluorescence could not reach a plateau for either protein-mediated sterol 
transfer within the observed duration of the assay and therefore, requires a 
longer period of monitoring in future (see Results, Section 3.4.3, Figure 32, 
B and D). 
In case of wtOSBP, lack of any significant difference in either the 
transfer rate or the amount of transferred ligand upon incorporation of PI(4)P 
in the acceptor membrane, was rather puzzling. At the estimated 1:1 molar 
ratio of protein to PI(4)P, under the experimental conditions, the wild-type 
protein was supposed to occupy more sites on the membranes compared to 
DOPC vesicles and exchange substantially more sterol for PI(4)P. One should 
be cautious while drawing meaningful conclusions from the transfer assay 
data because the signal obtained from FRET only represents energy transfer 
between two fluorophores, while the phenomenon occurring at the protein-
membrane interface is a culmination of protein association, ligand exchange 
and protein dissociation. Each of these events can affect the proximity of the 
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two fluorophores required for FRET to occur and therefore, FRET may not be 
an absolute indicator of sterol transfer. 
 
4.9. Concluding remarks 
The work presented here demonstrates the utility of label-free surface 
microanalysis technique, such as DPI, in characterizing the behaviour of 
LTPs. The biosensor-based approach enabled direct investigation of the 
protein-bilayer interaction and displayed unique hallmarks of OSBP’s 
binding behaviour that were distinguishable from the trends observed in 
radiolabeled/fluorescent ligand binding studies widely reported in the 
literature. The goal of this project was to study the interaction of OSBP and 
its mutants with simple immobilized phospholipid bilayers, containing 
different molar amounts of sterols and phosphoinositides. In agreement with 
the currently proposed models of lipid-transport mechanism by OSBP (de 
Saint-Jean et al., 2011; Mesmin et al., 2013), the wild-type protein showed 
higher binding affinity for membranes containing anionic phospholipid, 
PI(4)P, as compared to neutral PC bilayers. Interestingly, the membrane-
binding pattern of the protein remained unaltered when 25-
hydroxycholestrol, a natural ligand of OSBP, was incorporated in the 
membrane. With the help of OSBP-RR/EE (characterized by a dysfunctional 
PHD and lack of phosphoinositide recognition) and OSBP-HH/AA (with 
compromised ability to extract PI(4)P from membranes), I provided a clear 
evidence of monomeric extraction of PI(4)P from adsorbed bilayers by 
wtOSBP. 
The selectivity of OSBP in sequestering free sterols from solution was 
demonstrated by competitive binding of 25HC and cholesterol to the ORD 
saturated by 22-NBD-cholesterol. The ability of OSBP to deliver monomeric 
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cholesterol from solution to phospholipid vesicles was also demonstrated by 
the means of FRET between OSBP-bound 22-NBD-cholesterol and N-Rhod-
PE in the acceptor vesicles. However, the kinetic measurements of this 
phenomenon require further validation to obtain a better appreciation of 
rates. Taken together, my observations provide a more comprehensive 
molecular level description of the function of this protein in intracellular 
sterol trafficking and lay a foundation for in vivo investigations.  
In future, it will be of interest to utilize the DPI platform to examine if 
OSBP associates with membranes harbouring both sterols and the FFAT 
ligand VAP-A (an ER-resident protein), in a fashion similar to that of PI(4)P-
containing membranes. It will also be worthwhile to investigate if wtOSBP 
extracts PI(4)P when sterol-loaded protein is injected over surface-
immobilized membrane containing PI(4)P. If the sterol-loaded wtOSBP 
exhibits similar association profile as observed in case of free wtOSBP, then 
PI(4)P-extraction can be proven by performing a subsequent binding assay 
and injecting the protein on top of the PI(4)P-depleted membrane, without 
prior regeneration of the biosensor. OSBP’s ability to extract sterols in the 
presence of VAP-A should also be tested with OSBP mutant(s) with impaired 
oxysterol-binding ability. An example of one such mutant is OSBP-∆432–435 
that harbours a small deletion between the α-helical lid and β1-strand of the 
ORD (Bowden and Ridgway, 2008). The amino acids 409–459 map to the 
putative lid region of OSBP (Wang et al., 2008) and therefore, deletion of 
residues Glu-432, Leu-433, Ser-434 and Lys-435 causes impairment in sterol 
recognition and binding (Perry and Ridgway, 2006). Planar immobilized 
bilayers can be replaced with non-fused vesicles tethered to a chemically 
derivatized biosensor surface (Anderluh et al., 2005) for better comprehension 
of the role of membrane curvature on the binding affinity of OSBP. The 
membrane association of less characterized ORPs, such as ORP6, -7, -10 and -
11, should also be studied using the techniques highlighted in this thesis. 
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Supplemental Figure 1: Expression level of wtOSBP in Sf21 cells at various 
stages of baculovirus infection. SDS-PAGE (A) and Western blot (B) analyses of 
expression of wtOSBP in baculovirus-infected Sf21 culture, at the end of each day of 
incubation, are shown. Images represent the size-based separation of proteins 
obtained from the crude lysate of Sf21 cells at 24 h (lanes 8), 48 h (lane 9) and 72 h 
(lane 10) post-infection with baculovirus at an MOI of 0.1. Molecular weight markers 
were loaded in lanes 1 and 7. Although full images are shown, the lanes of interest 
are highlighted in red.  Therefore, readers are advised to ignore the results from 
lanes 2 – 6. Electrophoresis was performed on a 10% polyacrylamide gel and 
immunoblot samples were probed with mouse anti-OSBP mAb (dil. 1:200), as 
explained in Methods (Sections 2.5 and 2.6). Images were processed by Image 
Lab™ Software (ver. 5.2.1, Bio-Rad Laboratories Inc.).  
 
